Skip to main content Accessibility help

Chapter 12 - Non-atherosclerotic vasculopathies

from Part II - Stroke syndromes

Published online by Cambridge University Press: 05 August 2016

By

Louis R Caplan and

Edited by

Louis R. Caplan

Show author details

Louis R. Caplan: Affiliation:
Department of Neurology, Beth Israel Deaconess Medical Center, Massachusetts

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Chapter
Information: Caplan's Stroke
A Clinical Approach
, pp. 386 - 438

DOI: https://doi.org/10.1017/CBO9781316095805.013 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008.Google Scholar

Ojemann, RG, Fisher, CM, Rich, JC: Spontaneous dissecting aneurysms of the internal carotid artery. Stroke 1972;3:434–440.CrossRef Google Scholar

Fisher, CM, Ojemann, RG, Roberson, GH: Spontaneous dissection of cervicocerebral arteries. Can J Neurol Sci 1978;5:9–19.CrossRef Google Scholar

Baumgartner, RW, Bogousslavsky, J, Caso, V, Paciaroni, M (eds): Handbook on Cerebral Artery Dissection. Basel: Karger, 2005.Google Scholar

Caplan, LR: Dissections of brain-supplying arteries. Nat Clin Pract Neurol 2008;4:34–42.CrossRef Google Scholar PubMed

Debette, S, Leys, D: Cervical-artery dissections: Predisposing factors, diagnosis, and outcome. Lancet Neurol 2009;8:668–678.CrossRef Google Scholar PubMed

Caplan, LR, Zarins, C, Hemmatti, M: Spontaneous dissection of the extracranial vertebral artery. Stroke 1985;16:1030–1038.Google Scholar

Mokri, B, Houser, OW, Sandok, BA, Piepgras, DG: Spontaneous dissection of the vertebral arteries. Neurology 1988;38:880–885.CrossRef Google Scholar PubMed

Caplan, LR, Tettenborn, B: Vertebrobasilar occlusive disease: Review of selected aspects: I. Spontaneous dissection of extracranial and intracranial posterior circulation arteries. Cerebrovasc Dis 1992;2:256–265.Google Scholar

Barbour, PJ, Castaldo, JE, Rae-Grant, AD, et al: Internal carotid artery redundancy is significantly associated with dissection. Stroke 1994;25:1201–1206.Google Scholar

Giossi, A, Ritelli, M, Costa, P, et al: Connective tissue anomalies in patients with spontaneous cervical artery dissection. Neurology 2014;83:2032–2037.CrossRef Google Scholar PubMed

Brandt, T, Hausser, I, Orberk, E, et al: Ultrastructural connective tissue abnormalities in patients with spontaneous cervicocerebral artery dissections. Ann Neurol 1998;44:281–285.Google Scholar

Arnold, M, Fischer, U, Nedeltchev, K: Carotid artery dissection and sports. Kardiovaskuläre Medizin 2009;12:209–213.Google Scholar

Guillon, B, Peynet, J, Bertrand, M, et al: Do extracellular-matrix-regulating enzymes play a role in cervical artery dissections? Cerebrovasc Dis 2007;23:299–303.Google Scholar

Hart, RG, Easton, JD: Dissection of cervical and cerebral arteries. In Barnett, HJM (ed): Neurologic Clinics, vol 1. Philadelphia: Saunders, 1983, pp 155–182.Google Scholar

Friedman, WA, Day, AL, Quisling, RG, et al: Cervical carotid dissecting aneurysms. Neurosurgery 1980;7:207–214.CrossRef Google Scholar PubMed

Silbert, PL, Mokri, B, Schievink, WI: Headache and neck pain in spontaneous internal carotid and vertebral artery dissection. Neurology 1995;45:1517–1522.CrossRef Google Scholar

Bogousslavsky, J, Despland, PA, Regli, F: Spontaneous carotid dissection with acute stroke. Arch Neurol 1987;44:137–140.Google Scholar

Biousse, V, Schaison, M, Touboul, P-J, et al: Ischemic optic neuropathy associated with internal carotid artery dissection. Arch Neurol 1998;55:715–719.CrossRef Google Scholar PubMed

Pozzali, E, Giuliani, G, Poppi, M, Faenza, A: Blunt traumatic carotid dissection with delayed symptoms. Stroke 1989;20:412–416.CrossRef Google Scholar

Sturzenegger, M: Ultrasound findings in spontaneous carotid artery dissection: The value of duplex sonography. Arch Neurol 1991;48:1057–1063.CrossRef Google Scholar PubMed

Alecu, C, Fortrat, JO, Ducrocq, X, et al: Duplex scanning diagnosis of internal carotid artery dissections. Cerebrovasc Dis 2007;23:441–447.Google Scholar

Hennerici, M, Steinke, W, Rautenberg, W: High-resistance Doppler flow pattern in extracranial ICA dissection. Arch Neurol 1989;46:670–672.Google Scholar

Touboul, PJ, Mas, JL, Bousser, M-G, Laplane, D: Duplex scanning in extracranial vertebral artery dissection. Stroke 1987;18:116–121.Google Scholar

Caplan, LR, Gonzalez, RG, Buonanno, FS: Case 18–2012: A 35-year-old man with neck pain, hoarseness, and dysphagia. N Engl J Med 2012;366:2306–2313.Google Scholar

Krueger, BR, Okazaki, H: Vertebral-basilar distribution infarction following chiropractic cervical manipulation. Mayo Clin Proc 1980;55:322–332.Google Scholar PubMed

Sherman, DG, Hart, RG, Easton, JD: Abrupt change in head position and cerebral infarction. Stroke 1981;12:2–6.Google Scholar

Caplan, LR: Posterior circulation disease: Clinical Findings, Diagnosis, and Management. Boston: Blackwell Science, 1996.Google Scholar

Cook, JW, Sanstead, JK: Wallenberg’s syndrome following self-induced manipulation. Neurology 1991;41:1695–1696.Google Scholar

Rothrock, JF, Hesselink, JR, Teacher, TM: Vertebral artery occlusion and stroke from cervical self-manipulation. Neurology 1991;41:1696–1697.Google Scholar

Tramo, MJ, Hainline, B, Petito, F, et al: Vertebral artery injury and cerebellar stroke while swimming: Case report. Stroke 1985;16:1039–1042.Google Scholar

Hope, EE, Bodensteiner, JB, Barnes, P: Cerebral infarction related to neck position in an adolescent. Pediatrics 1983;72:335–337.Google Scholar

Bostrom, K, Liliequist, B: Primary dissecting aneurysm of the extracranial part of the internal carotid and vertebral arteries. Neurology 1967;17:179–186.Google Scholar

Grossman, FI, Davis, KR: Positional occlusion of the vertebral artery: A rare cause of embolic stroke. Neuroradiology 1982;23:227–230.Google Scholar

Tettenborn, B, Caplan, LR, Sloan, MA, et al: Postoperative brainstem and cerebellar infarcts. Neurology 1993;43:471–477.Google Scholar

Giroud, M, Gras, P, Dumas, R, Becker, F: Spontaneous vertebral artery dissection initially revealed by a pain in one upper arm. Stroke 1993;24:480–481.Google Scholar

Dubard, T, Pouchot, J, Lamy, C, et al: Upper limb peripheral motor deficits due to extracranial vertebral artery dissection. Cerebrovasc Dis 1994;4:88–91.Google Scholar

Goldsmith, P, Rowe, D, Jager, R, Kapoor, R: Focal vertebral artery dissection causing Brown–Séquard syndrome. J Neurol Neurosurg Psychiatry 1998;64:416–417.CrossRef Google Scholar

Yonas, H, Agamanolis, D, Takaoka, Y, White, RJ: Dissecting intracranial aneurysms. Surg Neurol 1977;8:407–415.Google Scholar

Caplan, LR, Baquis, G, Pessin, MS, et al: Dissection of the intracranial vertebral artery. Neurology 1988;38:868–879.Google Scholar

Anson, J, Crowell, RM: Cervicocranial arterial dissection. Neurosurg 1991;29:89–96.Google Scholar

O’Connell, B, Towfighi, J, Brennan, R, et al: Dissecting aneurysms of head and neck. Neurology 1985;35:993–997.Google Scholar

Chaves, C, Estol, C, Esnaola, MM, et al: Spontaneous intracranial internal carotid artery dissection. Arch Neurol 2002;59:977–981.Google Scholar

Caplan, LR, Estol, CJ, Massaro, AR: Dissection of the posterior cerebral arteries. Arch Neurol 2005;62:1138–1143.Google Scholar

de Bray, JM, Marc, G, Pautot, G, et al: Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis 2007;23:448–452.Google Scholar

Schievink, WI: The treatment of spontaneous carotid and vertebral artery dissections. Curr Opin Carotid 2000;15:316–321.CrossRef Google Scholar PubMed

Caprio, FZ, Bernstein, RA, Alberts, MJ, et al: Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections. Cerebrovasc Dis 2014;38:247–253.CrossRef Google Scholar PubMed

Kasner, SE, Hankins, LL, Bratina, P, Morganstern, LB: Magnetic resonance angiography demonstrates vascular healing of carotid and vertebral artery dissections. Stroke 1997;28:1993–1997.Google Scholar

Leclerc, X, Lucas, C, Godefroy, O, et al: Helical CT for the follow-up of cervical internal carotid artery dissections. AJNR Am J Neuroradiol 1998;19:831–837.Google Scholar

Engelter, ST, Brandt, T, Debette, S, et al: Antiplatelets versus anticoagulation in cervical artery dissection. Cervical Artery Dissection in Ischemic Stroke Patients 5(CADISP) Study Group. Stroke 2007;38:2605–2611.CrossRef Google Scholar

Georgiadis, D, Lanczik, O, Schwab, S, et al: IV thrombolysis in patients with acute stroke due to spontaneous carotid dissection. Neurology 2005;64:1612–1614.Google Scholar

Biller, J, Sacco, R, Albuquerque, FC, et al: Cervical arterial dissections and association with cervical manipulative therapy: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:3155–3174.Google Scholar

Kadkhodayan, Y, Jeck, DT, Moran, CJ, et al: Angioplasty and stenting in carotid artery dissection with or without associated pseudoaneurysm. AJNR Am J Neuroradiol 2005;26:2328–2335.Google Scholar

Lavallee, PC, Mazighi, M, Saint-Maurice, J-P, et al: Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion. Stroke 2007;38:2270–2274.Google Scholar

Ansari, SA, Thompson, BG, Gemmete, JJ, Gandhi, D: Endovascular treatment of distal cervical and intracranial dissections with the neuroform stent. Neurosurgery 2008;62:636–646.Google Scholar

Janjua, N, Qureshi, AI, Kirmani, J, Pullicino, P: Stent-supported angioplasty for acute stroke caused by carotid dissection. Neurocrit Care 2006;4:47–53.Google Scholar

Caplan, LR: Fibromuscular dysplasia. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 491–495.CrossRef Google Scholar

Slovut, DP, Olin, JW: Fibromuscular dysplasia. N Engl J Med 2004;350:1862–1871.Google Scholar

So, EL, Toole, JF, Dalal, P, et al: Cephalic fibromuscular dysplasia in 32 patients. Arch Neurol 1981;38:619–622.CrossRef Google Scholar PubMed

Corrin, LS, Sandok, BA, Houser, OW: Cerebral ischemic events in patients with carotid artery fibromuscular dysplasia. Arch Neurol 1981;38:616–618.Google Scholar

Sandok, BA: Fibromuscular dysplasia of the internal carotid artery. Neurol Clin 1983;1:17–26.Google Scholar

Luscher, TF, Lie, JT, Stanson, AW, et al: Arterial fibromuscular dysplasia. Mayo Clin Proc 1987;62:931–952.Google Scholar

Kubis, N, von Langsdorrff, D, Petitjean, C, et al: Thrombotic carotid megabulb: Fibromuscular dysplasia, septae, and ischemic stroke. Neurology 1999;52:883–886.Google Scholar

Mettinger, K, Ericson, K: Fibromuscular dysplasia and the brain. Stroke 1982;13:46–52.Google Scholar

Olin, JW, Froehlich, J, Gux, , et al: The United States Registry for Fibromuscular Dysplasia: Results in the first 447 patients. Circulation 2012;125:3182–3190.CrossRef Google Scholar PubMed

Finsterer, J, Strassegger, J, Haymerle, A, Hagmuller, G: Bilateral stenting and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry 2000;69:683–686.Google Scholar

Assadian, A, Senekowitsch, C, Assadian, O, et al: Combined open and endovascular stent grafting of internal carotid artery fibromuscular dysplasia: Long-term results. Eur J Vasc Endovasc Surg 2005;29:345–349.CrossRef Google Scholar PubMed

Olin, JW, Gornik, HL, Bacharach, JM, Biller, J, et al: Fibromusclar dysplasia: State of the science and critical unanswered questions. A Scientific Statement from the American Heart Association. Circulation 2014;129:1048–1078.Google Scholar

Pessin, MS, Chung, C-S: Eales disease and Gröenblad-Strandberg disease (pseudoxanthoma elasticum). In Bogousslavsky, J, Caplan, LR (eds): Stroke Syndromes. Cambridge: Cambridge University Press, 1995, pp 443–447.Google Scholar

Lebwohl, MG, Distefano, D, Prioleau, PG, et al: Pseudoxanthoma elasticum and mitral-valve prolapse. N Engl J Med 1982;307:228–231.Google Scholar

Caplan, LR, Chung, C-S: Pseudoxanthoma elasticum. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 135–138.Google Scholar

Laube, S, Moss, C: Pseudoxanthoma elasticum. Arch Dis Child 2005;90:754–756.Google Scholar

Strole, WE, Margolis, R: Case records of the Massachusetts General Hospital: Case 10–1983. N Engl J Med 1983;308:579–585.Google Scholar

Altman, LK, Fialkow, PJ, Parker, F, et al: Pseudoxanthoma elasticum: An underdiagnosed genetically heterogenous disorder with protean manifestations. Arch Intern Med 1974;134:1048–1054.Google Scholar

Rios-Montenegro, E, Behrens, MM, Hoyt, WF: Pseudoxanthoma elasticum: Association with bilateral carotid rete mirabile and unilateral carotid-cavernous sinus fistula. Arch Neurol 1972;26:151–155.Google Scholar

Roach, ES: Ehlers–Danlos syndrome. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 139–144.Google Scholar

Byers, PH: Ehlers–Danlos syndrome type IV: A genetic disorder in many guises. J Invest Dermatol 1995;105:311–313.Google Scholar

Leier, CV, Call, TD, Fulkerson, PK, Wooley, CF: The spectrum of cardiac defects in the Ehlers–Danlos syndrome types I and III. Ann Intern Med 1980;92:171–178.Google Scholar

Pretorius, ME, Butler, IJ: Neurologic manifestations of Ehlers–Danlos syndrome. Neurology 1983;33:1087–1089.Google Scholar

Lach, B, Nair, SG, Russell, NA, Benoit, BG: Spontaneous carotid-cavernous fistula and multiple arterial dissections in type IV Ehlers–Danlos syndrome. J Neurosurg 1987;66:462–467.Google Scholar

Sareli, AE, Janssen, WJ, Sterman, D, et al: What’s the connection? N Engl J Med 2008;358:626–632.Google Scholar

North, KN, Whiteman, DAH, Pepin, MG, Byers, PH: Cerebrovascular complications in Ehlers–Danlos syndrome type IV. Ann Neurol 1995;38:960–964.Google Scholar

Schievink, WI, Limburg, M, Oorthuys, JW, et al: Cerebrovascular disease in Ehlers–Danlos syndrome type IV. Stroke 1990;21:626–632.Google Scholar

Schievink, WI, Parisi, JE, Piepgras, DG, Michels, VV: Intracranial aneurysms in Marfan’s syndrome: An autopsy study. Neurosurgery 1997;41:866–870.Google Scholar

Conway, JE, Hutchins, GM, Tamargo, RJ: Marfan syndrome is not associated with intracranial aneurysms. Stroke 1999;30:1632–1636.Google Scholar

Pyeritz, RE: The Marfan syndrome. Annu Rev Med 2000;51:481–510.Google Scholar

Cunha, L: Marfan’s syndrome. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 131–134.CrossRef Google Scholar

Kainulainen, K, Pulkkinen, L, Savolainen, A, et al: Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med 1990;323:935–939.Google Scholar

Schievink, WI, Björnsson, J, Piepgras, DG: Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan’s syndrome and bilateral carotid artery dissections. Stroke 1994;12:2492–2496.Google Scholar

Youl, BD, Coutellier, A, Dubois, B, et al: Three cases of spontaneous extracranial vertebral artery dissection. Stroke 1990;4:618–625.Google Scholar

van den Berg, JS, Limburg, M, Hennekam, RC: Is Marfan syndrome associated with symptomatic intracranial aneurysms? Stroke 1996;27:10–12.Google Scholar

Loeys, BL, Chen, J, Neptune, ER, et al: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005;37:275–281.Google Scholar

Loeys, BL, Schwarze, U, Holm, T, et al: Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006;355:788–798.Google Scholar

LeMaire, SA, Pannu, H, Tran-Fadulu, V, et al: Severe aortic and arterial aneurysms associated with TGFBR2 mutation. Nat Clin Pract Cardiovasc Med 2007;4:167–171.Google Scholar

Savitz, S, Caplan, LR: Dilatative arteriopathy (dolichoectasia). In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 479–482.Google Scholar

Lou, M, Caplan, LR: Vertebrobasilar dilatative arteriopathy (dolichoectasia). Ann NY Acad Sci 2010;1184:121–133.Google Scholar

Smoker, WR, Price, MJ, Keyes, WD, et al: High-resolution computed tomography of the basilar artery: 1. Normal size and position. AJNR Am J Neuroradiol 1986;7:55–60.Google Scholar

Pico, F, Labreuche, J, Cohen, A, et al: Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta. Neurology 2004;63:2016–2021.Google Scholar

Read, D, Esiri, MM: Fusiform basilar artery aneurysm in a child. Neurology 1979;29:1045–1049.Google Scholar

Hirsch, CS, Roessmann, U: Arterial dysplasia with ruptured basilar artery aneurysm: Report of a case. Hum Pathol 1975;6:749–758.Google Scholar

Makos, MM, McComb, RD, Hart, MN, Bennett, DR: Alpha-glucosidase deficiency and basilar artery aneurysm: Report of a sibship. Ann Neurol 1987;22:629–633.Google Scholar

Schwartz, A, Rautenberg, W, Hennerici, M: Dolichoectatic intracranial arteries: Review of selected aspects. Cerebrovasc Dis 1993;3:273–279.Google Scholar

Caplan, LR: Dilatative arteriopathy (dolichoectasia): What is known and not known. Ann Neurol 2005;57:469–471.Google Scholar

Pico, F, Labreuche, J, Touboul, PJ, Amarenco, P: Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology 2003;61:1736–1742.Google Scholar

Pico, F, Labreuche, J, Touboul, PJ, et al: Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol 2005;57:472–479.Google Scholar

Pessin, MS, Chimowitz, MI, Levine, SR, et al: Stroke in patients with fusiform vertebrobasilar aneurysms. Neurology 1989;39:16–21.Google Scholar

Moseley, IF, Holland, IM: Ectasia of the basilar artery: The breadth of the clinical spectrum and the diagnostic value of computed tomography. Neuroradiology 1979;18:83–91.Google Scholar

Little, JR, St Louis, P, Weinstein, M, et al: Giant fusiform aneurysms of the cerebral arteries. Stroke 1981;12:183–188.Google Scholar

Echiverri, HC, Rubino, FA, Gupta, SR, Gujrati, M: Fusiform aneurysm of the vertebrobasilar arterial system. Stroke 1989;20:1741–1747.Google Scholar

Nishizaki, T, Tamaki, N, Takeda, N, et al: Dolichoectatic basilar artery: A review of 23 cases. Stroke 1986;17:1277–1281.Google Scholar

Shokunbi, MT, Vinters, HV, Kaufmann, JC: Fusiform intracranial aneurysms: Clinicopathologic features. Surg Neurol 1988;29:263–270.Google Scholar

Savitz, SI, Ronthal, M, Caplan, LR: Vertebral artery compression of the medulla. Arch Neurol 2006;63:234–241.Google Scholar

DeGeorgia, M, Belden, J, Pao, L, et al: Thrombus in vertebrobasilar dolichoectatic artery treated with intravenous urokinase. Cerebrovasc Dis 1999;9:28–33.Google Scholar

Cohen, MM, Hemalatha, CP, D’Addario, RT, Goldman, HW: Embolism from a fusiform middle cerebral artery aneurysm. Stroke 1980;11:158–161.Google Scholar

Aichner, FT, Felber, SR, Birhamer, GG, Posch, A: Magnetic resonance imaging and magnetic resonance angiography of vertebrobasilar dolichoectasia. Cerebrovasc Dis 1993;3:280–284.Google Scholar

Hennerici, M, Rautenberg, W, Schwartz, A: Trans-cranial Doppler ultrasound for the assessment of intracranial arterial flow velocity: II. Evaluation of intracranial arterial disease. Surg Neurol 1987;27:523–532.Google Scholar

Passero, S, Rossi, S: Natural history of vertebrobasilar dolichoectasia. Neurology 2008;70:66–72.Google Scholar

Vinters, HV: Cerebral amyloid angiopathy: A critical review. Stroke 1987;18:311–324.Google Scholar

Cordonnier, C, Leys, D: Cerebral amyloid angiopathies. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 455–464.Google Scholar

Vinters, HV, Gilbert, JJ: Cerebral amyloid angiopathy: Incidence and complications in the aging brain: II. The distribution of amyloid vascular changes. Stroke 1983;14:924–928.CrossRef Google Scholar PubMed

Okazaki, H, Reagan, TJ, Campbell, RJ: Clinicopathological studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979;54:22–31.Google Scholar

Cosgrove, G, Leblanc, R, Meagher-Villemure, K, et al: Cerebral amyloid angiopathy. Neurology 1985;34:625–631.CrossRef Google Scholar

Gilbert, JJ, Vinters, HV: Cerebral amyloid angiopathy: Incidence and complications in the aging brain: I. Cerebral hemorrhage. Stroke 1983;14:915–923.Google Scholar

Kase, CS: Cerebral amyloid angiopathy. In Kase, CS, Caplan, LR (eds): Intracerebral Hemorrhage. Boston: Butterworth–Heinemann, 1994, pp 179–200.Google Scholar

Viswanathan, A, Greenberg, SM: Cerebral amyloid angiopathy in the elderly. Ann Neurol 2011;70:871–880.CrossRef Google Scholar PubMed

Greenberg, SM, Eng, JA, Ning, M, et al: Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004;35:1415–1420.CrossRef Google Scholar PubMed

Greenberg, SM, Finklestein, SP, Schaefer, PW: Petechial hemorrhages accompanying lobar hemorrhage: Detection by gradient-echo MRI. Neurology 1996;46:1751–1754.CrossRef Google Scholar PubMed

Kumar, S, Goddeau, RP, Selim, MH, et al. Atraumatic convexal subarachnoid hemorrhage: Clinical presentation, imaging patterns, and etiologies. Neurology 2010;74:893–899.Google Scholar

Beitzke, M, Gattringer, T, Enzinger, C, Wagner, G, Niederkorn, K, Fazekas, F: Clinical presentation and long term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage. Stroke 2011;42:3055–3060.Google Scholar

Linn, J, Herms, J, Bruckmann, H, Fesl, G, Freilinger, T, Wiesmann, M: Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 2008;29:184–186.Google Scholar

Linn, J, Halpin, A, Demaerel, P, et al: Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010;74:1346–1350.Google Scholar

Shoamanesh, A, Martinez-Ramirez, S, Oliveira-Filho, J, et al: Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology 2014;83:1838–1843.Google Scholar

Greenberg, SM, Hyman, BT: Cerebral amyloid angiopathy and apolipoprotein E: Bad news for the good allele? Ann Neurol 1997;41:701–702.Google Scholar

O’Donnell, HC, Rosand, J, Knudsen, KA, et al: Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000;342:240–245.Google Scholar

McCarron, MO, Nicoll, JA, Ironside, JW, et al: Cerebral amyloid angiopathy-related hemorrhage. I. Interaction of APOE ε2 with putative clinical risk factors. Stroke 1999;30:1643–1646.Google Scholar

Smith, DB, Hitchcock, M, Philpott, PJ: Cerebral amyloid angiopathy presenting as transient ischemic attacks: Case report. J Neurosurg 1985;63:963–964.Google Scholar

Gray, F, Dubas, F, Roullet, E, Escourolle, R: Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985;18:54–59.Google Scholar

Loes, DJ, Biller, J, Yuh, WTC, et al: Leukoencephalopathy in cerebral amyloid angiopathy: MR imaging in four cases. AJNR Am J Neuroradiol 1990;11:485–488.Google Scholar

DeWitt, LD, Louis, DN: Case records of the Massachusetts General Hospital: Case 27–1991. N Engl J Med 1991;325:42–54.Google Scholar

Greenberg, SM, Vonsattel, JPG, Stakes, JW, et al: The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage. Neurology 1993;43:2073–2079.Google Scholar

Grubb, A, Jensson, O, Gudmundsson, G, et al: Abnormal metabolism of Y-trace alkaline microprotein: The basic defect in hereditary cerebral hemorrhage with amyloidosis. N Engl J Med 1984;311:1547–1549.Google Scholar

Stefansson, K, Antel, JP, Ojer, J, et al: Autosomal dominant cerebrovascular amyloidosis: Properties of peripheral blood lymphocytes. Ann Neurol 1980;7:436–440.Google Scholar

Fountain, NB, Eberhard, DA: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: Report of two cases and review of the literature. Neurology 1996;46:190–197.Google Scholar

Caplan, LR: Case records of the Massachusetts General Hospital. Case 10–2000. N Engl J Med 2000;342:957–964.CrossRef Google Scholar

Eng, JA, Frosch, MP, Choi, K, et al: Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004;55:250–256.Google Scholar

Marotti, JD, Savitz, SI, Kim, W-K, et al: Cerebral amyloid angiitis progressing to generalized angiitis and leucoencephalitis. Neuropathol Appl Neurobiol 2007;33:1–5.Google Scholar

Scolding, NJ, Joseph, F, Kirby, PA, et al: Aβ-related angiitis: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy.Brain 2005;128:500–515.Google Scholar

Chung, KK, Anderson, NE, Hutchinson, D, Syneck, B, Barbar, PA: Cerebral amyloid angiopathy related inflammation: Three case reports and a review. J Neurol Neurosurg Psychiatry 2011;82:20–26.Google Scholar

Salvarani, C, Hunder, GG, Morris, JM, Brown, RD Jr, Christianson, T, Giannini, C: Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology 2013;81:1596–1603.Google Scholar

Greene, GM, Godersky, JC, Biller, J, et al: Surgical experience with intracerebral hemorrhage secondary to cerebral amyloid angiopathy. Stroke 1990;21:170.Google Scholar

Izumihara, A, Ishihara, T, Iwamoto, N, et al: Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Stroke 1999;30:29–33.Google Scholar

Greenberg, SM: Cerebral amyloid angiopathy. Prospects for clinical diagnosis and treatment. Neurology 1998;51:690–694.Google Scholar

Greenberg, SM, Salman, RA-S, Biessels, GJ, et al: Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol 2014;13:419–428.Google Scholar

van de Beek, D, de Gans, J, Spanjaard, L, et al: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849–1859.Google Scholar

van de Beek, D, de Gans, J, Tunkel, AR, et al: Community-acquired bacterial meningitis in adults. N Engl J Med 2006;354:44–53.Google Scholar

Bentley, P, Quadri, F, Wild, EJ, et al: Vasculitic presentation of staphylococcal meningitis. Arch Neurol 2007;64:1788–1789.Google Scholar

O’Farrell, R, Thornton, J, Brennan, P, et al: Spinal cord infarction and tetraplegia – Rare complications of meningococcal meningitis. Br J Anesth 2000;84:514–517.Google Scholar

van de Beek, D, Patel, R, Wijdicks, EFM: Meningococcal meningitis with brainstem infarction. Arch Neurol 2007;64:1350–1351.Google Scholar

Weinstein, AJ, Schianone, WA, Furlan, AJ: Listeria rhomboencephalitis. Arch Neurol 1982;39:514–516.Google Scholar

Brown, RH, Sobel, RA: Case records of the Massachusetts General Hospital. N Engl J Med 1989;321:739–750.Google Scholar

Frayne, J, Gates, P: Listeria rhomboencephalitis. Clin Exp Neurol 1987;24:175–179.Google Scholar

Silvestri, N, Ajani, Z, Savitz, S, Caplan, LR: A 73-year-old woman with an acute illness causing fever and cranial nerve abnormalities. Rev Neurol Dis 2006; 3:29–30, 35–37.Google Scholar

Windsor, JJ: Cat-scratch disease: Epidemiology, aetiology and treatment. Br J Biomed Sci 2001;58:101–110.Google Scholar

Selby, G, Walker, GL: Cerebral arteritis in cat-scratch disease. Neurology 1979;29:1413–1418.Google Scholar

Davis, LE, Graham, GD: Neurosyphilis and stroke. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 35–40.Google Scholar

Flint, AC, Liberato, BB, Anziska, Y, et al: Meningovascular syphilis as a cause of basilar artery stenosis. Neurology 2005;64:391–392.Google Scholar

Gaa, J, Weidauer, S, Sitzer, M, et al: Cerebral vasculitis due to treponema pallidum infection: MRI and MRA findings. Eur Radiol 2004;14:746–747.Google Scholar

Golden, MR, Marra, CM, Holmes, KK: Update on syphilis: Resurgence of an old problem. JAMA 2003;290:1510–1514.Google Scholar

Rahn, DW, Malawista, SE: Lyme disease: Recommendations for diagnosis and treatment. Ann Intern Med 1991;114:472–481.Google Scholar

Steere, AC, Sikand, VK: The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med 2003;348:2472–2474.Google Scholar

Halperin, JJ, Luft, BJ, Anand, AK, et al: Lyme neuroboreliosis: Central nervous system manifestations. Neurology 1989;39:753–759.Google Scholar

Pachner, AR, Duray, P, Steere, AC: Cerebral nervous system manifestations of Lyme disease. Arch Neurol 1989;46:790–795.Google Scholar

Uldry, PA, Regli, F, Bogousslavsky, J: Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection. J Neurol Neurosurg Psychiatry 1987;50:1703–1704.Google Scholar

Schmiedel, J, Gahn, G, von Kummer, R, Reichmann, H: Cerebral vasculitis with multiple infarcts caused by Lyme disease. Cerebrovasc Dis 2004;17:79–81.Google Scholar

Halperin, JJ: Stroke in Lyme disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 59–66.Google Scholar

Katrak, SM: Vasculitis and stroke due to tuberculosis. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 41–46.Google Scholar

Leiguarda, R, Berthier, M, Starkstein, S, et al: Ischemic infarction in 25 children with tuberculous meningitis. Stroke 1988;19:200–204.Google Scholar

Katrak, SM, Shembalkar, PK, Bijwe, SR, Bhandarkar, LD: The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human deficiency virus infection. J Neurol Sci 2000;181:118–126.Google Scholar

Bernaerts, A, Vanhoenacker, FM, Parizel, PM, et al: Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003;13:1876–1890.Google Scholar

Chan, KH, Cheung, RT, Lee, R, et al: Cerebral infarcts complicating tuberculous meningitis. Cerebrovasc Dis 2005;19:391–395.Google Scholar

Hier, DB, Caplan, LR: Stroke due to fungal infections. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 47–52.Google Scholar

Kobayashi, RM, Coil, M, Niwayama, G, Trauner, D: Cerebral vasculitis in coccidioidal meningitis. Ann Neurol 1977;1:281–284.Google Scholar

Walsh, TJ, Hier, DB, Caplan, LR: Fungal infection of the central nervous system: Comparative analysis of the risk factors and clinical signs in 57 patients. Neurology 1985;35:1654–1657.Google Scholar

Walsh, TJ, Hier, DB, Caplan, LR: Aspergillosis of the central nervous system: Clinicopathological analysis of 17 patients. Ann Neurol 1985;18:574–582.Google Scholar

Kleinschmidt-DeMasters, BK: Central nervous system aspergillosis: A 20 year retrospective series. Hum Pathol 2002;33:116–124.Google Scholar

Rangel-Guerra, R, Martinez, HR, Saenz, C, et al: Rhinocerebral and systemic mucormycosis. Clinical experience in 36 cases. J Neurol Sci 1996;143:19–30.Google Scholar

Moore, PM, Cupps, TR: Neurologic complications of vasculitis. Ann Neurol 1983;14:155–167.Google Scholar

Bischof, M, Baumgartner, RW: Varicella-zoster and other virus-related cerebral vasculopathy. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 17–26.Google Scholar

Gilden, DH, Kleinschmidt-DeMasters, BK, Wellish, M, et al: Varicella-zoster virus, a cause of waxing and waning vasculitis: The New England Journal of Medicine case 5–1995 revisited. Neurology 1996;47:1441–1446.Google Scholar

Bourdette, DN, Rosenberg, NL, Yatsu, FM: Herpes zoster ophthalmicus and delayed ipsilateral cerebral infarction. Neurology 1983;33:1428–1432.Google Scholar

Hilt, DC, Buchholz, D, Krumholz, A, et al: Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: Diagnosis and management approaches. Ann Neurol 1983;14:543–553.Google Scholar

Doyle, PW, Gibson, G, Dolman, C: Herpes zoster ophthalmicus with contralateral hemiplegia: Identification of cause. Ann Neurol 1983;14:84–85.Google Scholar

Nagel, MA, Cohrs, RJ, Mahalingam, R, et al: The varicella zoster virus vasculopathies. Clinical, CSF, imaging and virologic features. Neurology 2008;70:853–860.Google Scholar

Powers, JM: Herpes zoster maxillaris with delayed occipital infarction. J Clin Neuroophthalmol 1986;2:113–115.Google Scholar

Snow, BJ, Simcock, JP: Brainstem infarction following cervical herpes zoster. Neurology 1988;38:1331.Google Scholar

Ross, MH, Abend, WK, Schwartz, RB, Samuels, MA: A case of C2 herpes zoster with delayed bilateral pontine infarction. Neurology 1991;41:1685–1686.Google Scholar

Caekebeke, JFV, Peters, ACB, Vandvik, B, et al: Cerebral vasculopathy associated with primary varicella infection. Arch Neurol 1990;47:1033–1035.Google Scholar

Askalan, R, Laughlin, S, Mayank, S, et al: Chickenpox and stroke in childhood: A study of frequency and causation. Stroke 2001;32:1257–1262.Google Scholar

Hausler, MG, Ramaekers, VT, Reul, J, et al: Early and late onset manifestations of cerebral vasculitis related to varicella zoster. Neuropediatrics 1998;29:202–207.Google Scholar

Lanthier, S, Armstrong, D, Domi, T, deVeber, G: Post-varicella arteriopathy of childhood. Neurology 2005;64:660–663.Google Scholar

Melanson, M, Chalk, C, Georgevich, L, et al: Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: Evidence for viral invasion of cerebral arteries. Neurology 1996;47:569–570.Google Scholar

Saito, K, Moskowitz, MA: Contributions from the upper cervical dorsal roots and trigeminal ganglia to the feline circle of Willis. Stroke 1989;20:524–526.Google Scholar

Pinto, AN: AIDS and cerebrovascular disease. Stroke 1996;27:538–543.Google Scholar

Gillams, AR, Allen, E, Hrieb, K, et al: Cerebral infarction in patients with AIDS. AJNR Am J Neuroradiol 1997;18:1581–1585.Google Scholar

Cole John, W, Pinto, AN, Hebel, JR, et al: Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004;35:51–56.Google Scholar

Berger, JR: AIDS and stroke risk. Lancet Neurol 2004;3:206–207.Google Scholar

Fritz, V, Bryer, A: Stroke in persons infected with HIV. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 93–100.Google Scholar

Dubrovsky, T, Curless, R, Scott, G, et al: Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology 1998;51:560–565.Google Scholar

Lipton, J, Rivkin, MJ: Kawasaki disease: Cerebrovascular and neurologic complications. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 81–86.Google Scholar

Amano, S, Hazama, F, Hamashima, Y: Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J 1979;43:741–748.Google Scholar

Amano, S, Hazama, F, Kubagawa, H, et al: General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980;30:681–694.Google Scholar

Del Bruto, OH: Stroke and vasculitis in patients with cysticercosis. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 53–58.Google Scholar

García, HH, Del Brutto, OH: Neurocysticercosis: Updated concepts about an old disease. Lancet Neurol 2005;4:653–661.Google Scholar

Escobar, A, Weidenheim, KM: The pathology of neurocysticercosis. In Singh, G, Prabhakar, S (eds): Taenia Solium Cysticercosis. From Basic to Clinical Science. Wallingford, Oxon, UK: CAB International, 2002, pp 289–305.Google Scholar

Caplan, LR: How to manage patients with neurocysticercosis. Eur Neurol 1997;37:124–131.Google Scholar

Rodriguez-Carbajal, J, del Brutto, OH, Penagos, P, et al: Occlusion of the middle cerebral artery due to cysticercotic angiitis. Stroke 1989;20:1095–1099.Google Scholar

Monteiro, L, Almeida-Pinto, J, Leite, I, et al: Cerebral cysticercus arteritis: Five angiographic cases. Cerebrovasc Dis 1994;4:125–133.Google Scholar

Barinagarrementaria, F, Cantu, C: Frequency of cerebral arteritis in subarachnoid cysticercosis. An angiographic study. Stroke 1998;29:123–125.Google Scholar

Cantu, C, Villarreal, J, Soto, JL, Barinagarrementaria, F: Cerebral cysticercotic arteriits: Detection and follow-up by transcranial Doppler. Cerebrovasc Dis 1998;8:2–7.Google Scholar

Bang, OY, Heo, JH, Choi, SA, Kim, DI: Large cerebral infarction during praziquantel therapy in neurocysticercosis. Stroke 1997;28:211–213.Google Scholar

Newton, CR, Warrell, DA: Neurological manifestations of falciparum malaria. Ann Neurol 1998;43:695–702.Google Scholar

Gall, C, Spuler, A, Fraunberger, P: Subarachnoid hemorrhage in a patient with cerebral malaria. N Engl J Med 1999 341:611–613.Google Scholar

Omanga, U, Ntihinyurwa, M, Shako, D, Mashako, M: Les hemiplegies au cours de l’acces pernicieux a Plasmodium falciparum de l’enfant. Ann Pediatr (Paris) 1983;30:294–296.Google Scholar

Newton, CR, Marsh, K, Peshu, N, Kirkham, FJ: Perturbations of cerebral hemodynamics in Kenyan children with cerebral malaria. Pediatr Neurol 1996;15:41–49.Google Scholar

Massaro, AR: Cerebrovascular problems in Chagas disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 87–92.Google Scholar

Carod-Artal, FJ, Vargas, AP, Melo, M, Horan, TA: American trypanosomiasis (Chagas’ disease): An unrecognised cause of stroke. J Neurol Neurosurg Psychiatry 2003;74:516–518.Google Scholar

Carod-Artal, FJ, Vargas, AP, Horan, TA, Nunes, LG: Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005;36:965–970.Google Scholar

Leon-Sarmiento, FE, Mendoza, E, Torres-Hillera, M, et al: Trypanosoma cruzi-associated cerebrovascular disease: A case-control study in Eastern Colombia. J Neurol Sci 2004;217:61–64.Google Scholar

Oliveira-Filho, J, Viana, LC, Vieira de Melo, RM, et al: Chagas disease is an independent risk factor for stroke: Baseline characteristics of a Chagas disease cohort. Stroke 2005;36:2015–2017.Google Scholar

Carod-Artal, FJ, Gascon, J: Chagas disease and stroke. Lancet Neurol 2010;9:533–542.Google Scholar

Fauci, AS, Haynes, BF, Katz, P: The spectrum of vasculitis: Clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978;89:660–676.Google Scholar

Moore, PM, Richardson, B: Neurology of the vasculitides and connective tissue disease. J Neurol Neurosurg Psychiatry 1998;65:10–22.Google Scholar

Scott, DG: Classification and treatment of systemic vasculitis. Br J Rheumatol 1988;27:251–257.Google Scholar

Moore, PM, Fauci, AS: Neurologic manifestations of systemic vasculitis: A retrospective and prospective study of the clinico-pathologic features and responses to therapy in 25 patients. Am J Med 1981;71:517–524.Google Scholar

Kissel, JT, Rammohan, KW: Pathology and therapy of nervous system vasculitis. Clin Neuropharmacol 1991;14:28–48.Google Scholar

Moore, PM, Richardson, B: Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry 1998;65:10–22.Google Scholar

Villringer, A, Moore, PM: Vasculitides and other nonatherosclerotic vasculopathies of the nervous system. In Brandt, T, Caplan, LR, Dichgans, J, et al. (eds): Neurological Disorders. San Diego: Academic Press, 1996, pp 305–327.Google Scholar

Reichhart, MD, Meuli, R, Bogousslavsky, J: Microscopic polyangiitis (MPA) and polyarteritis nodosa (PAN). In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 311–330.Google Scholar

Caplan, LR, Hedley-White, ET: Case records of the Massachusetts General Hospital: Case 5–1995. N Engl J Med 1995;332:452–459.Google Scholar

Mehdirrata, M, Caplan, LR: Churg–Strauss syndrome. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 331–334.Google Scholar

Churg, J, Strauss, L: Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951;27:277–301.Google Scholar

Chumbley, LC, Harrison, EG, DeRemee, RA: Allergic granulomatosis and angiitis (Churg–Strauss syndrome): Report and analysis of 30 cases. Mayo Clin Proc 1977;52:477–484.Google Scholar

Sehgal, M, Swanson, JW, DeRemee, RA, Colby, TV: Neurologic manifestations of Churg–Strauss syndrome. Mayo Clin Proc 1995;70:337–341.Google Scholar

Hauser, SL, Shahani, B, Hedley-White, ET: Case records of the Massachusetts General Hospital: Case 38–1990. N Engl J Med 1990;323:812–822.Google Scholar

Jennette, JC, Falk, RJ: Small-vessel vasculitis. N Engl J Med 1997;337:1512–1523.Google Scholar

Savitz, S, Caplan, LR: Cerebrovascular complications of Henoch– Schönlein purpura. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 309–310.Google Scholar

Chiaretti, A, Caresta, E, Piastra, M, et al: Cerebral hemorrhage in Henoch– Schönlein syndrome. Childs Nerv Syst 2002;18:365–367.Google Scholar

Eun, SH, Kim, SJ, Cho, DS, et al: Cerebral vasculitis in Henoch– Schönlein purpura: MRI and MRA findings, treated with plasmapharesis alone. Pediatr Int 2003;45:484–487.Google Scholar

Fauci, AS, Haynes, BF, Katz, P, Wolff, SM: Wegener’s granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76–85.Google Scholar

Haynes, BF, Fishman, ML, Fauci, AS, Wolff, SM: The ocular manifestations of Wegener’s granulomatosis: Fifteen years’ experience and review of the literature. Am J Med 1977;63:131–141.Google Scholar

Lapresle, J, Lasjaunias, P: Cranial nerve ischemic arterial syndromes. Brain 1985;109:207–215.Google Scholar

Palaic, M, Yeadon, C, Moore, S, Cashman, N: Wegener’s granulomatosis mimicking temporal arteritis. Neurology 1991;41:1694–1695.Google Scholar

Frohman, LP, Lama, P: Annual review of systemic diseases: 1995–1996, part 1. J Neuroophthalmol 1998;18:67–79.Google Scholar

Satoh, J, Miyasaka, N, Yamada, T, et al: Extensive cerebral infarction due to involvement of both anterior cerebral arteries by Wegener’s granulomatosis. Ann Rheum Dis 1988;47:606–611.Google Scholar

Provenzale, JM, Allen, NB: Wegener granulomatosis: CT and MR findings. AJNR Am J Neuroradiol 1996;17:785–792.Google Scholar

Nölle, B, Specks, U, Lüdemann, J, et al: Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener’s granulomatosis. Ann Intern Med 1989;111:28–40.Google Scholar

Feinglass, EJ, Arnett, SC, Dorsch, CA, et al: Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976;55:323–339.Google Scholar

Futrell, N: Systemic lupus erythematosus. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 335–342.Google Scholar

Johnson, RT, Richardson, EP: The neurological manifestations of systemic lupus erythematosus: A clinical–pathological study of 24 cases and review of the literature. Medicine (Baltimore) 1968;47:337–369.Google Scholar

Devinsky, O, Petito, C, Alonso, D: Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23:380–384.Google Scholar

Alsen, AM, Gabrulsen, TO, McCune, WJ: MR imaging of systemic lupus erythematosus involving the brain. AJNR Am J Neuroradiol 1985;6:197–201.Google Scholar

Trevor, RF, Sondheimer, FK, Fessel, WJ, et al: Angiographic demonstration of major cerebral vessel occlusion in systemic lupus erythematosus. Neuroradiology 1972;4:202–207.Google Scholar

Hart, R, Miller, V, Coull, B, et al: Cerebral infarction associated with lupus anticoagulants: Preliminary report. Stroke 1984;15:114–118.Google Scholar

McVerry, BA, Machin, SJ, Parry, H, et al: Reduced prostacycline activity in systemic lupus erythematosus. Ann Rheum Dis 1980;39:524–525.Google Scholar

Galve, E, Candell-Riera, J, Pigrau, C, et al: Prevalence, morphological types, and evaluation of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988;319:817–823.Google Scholar

Moncayo-Gaete, J: Thrombotic thrombocytopenic purpura. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 301–308.Google Scholar

Petitt, RM: Thrombotic thrombocytopenic purpura: A thirty year review. Semin Thromb Hemost 1980;6:350–355.Google Scholar

Kwaan, HC: Clinicopathological features of thrombotic thrombocytopenic purpura. Semin Hematol 1987;24:71–81.Google Scholar

Silverstein, A: Thrombotic thrombocytopenic purpura: The initial neurological manifestations. Arch Neurol 1968;18:358–362.Google Scholar

Rinkel, G, Wijdicks, E, Hene, RJ: Stroke in relapsing thrombotic thrombocytopenic purpura. Stroke 1991;22:1087–1088.Google Scholar

Kelly, PJ, McDonald, CT, Neill, GO, et al: Middle cerebral artery main stem thrombosis in two siblings with familial thrombocytopenic purpura. Neurology 1998;50:1157–1160.Google Scholar

Bakshi, R, Shaikh, ZA, Bates, VE, Kinkel, PR: Thrombotic thrombocytopenic purpura: Brain CT and MRI findings in 12 patients. Neurology 1999;52:1285–1288.Google Scholar

Hinchey, J, Chaves, C, Apignani, B, et al: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.Google Scholar

Bennett, CL, Weinberg, PD, Rozenberg-Ben-Dror, K, et al: Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med 1998;128, 541–544.Google Scholar

Bennett, CL, Connors, JM, Carwile, JM, et al: Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:1773–1777.Google Scholar

Zakarija, A, Bennett, C: Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 2005;31:681–690.Google Scholar

Shepard, KV, Bukowski, RM: The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions and plasma exchange. Semin Hematol 1987;24:178–193.Google Scholar

Rubens, E, Savitz, S: Rheumatoid arthritis and cerebrovascular disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 343–346.Google Scholar

Ramos, M, Mandybur, TI: Cerebral vasculitis in rheumatoid arthritis. Arch Neurol 1975;32:271–275.Google Scholar

Watson, P: Intracranial hemorrhage with vasculitis in rheumatoid arthritis. Arch Neurol 1979;36:58.Google Scholar

Watson, P, Fekete, J, Dick, J: Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci 1977;4:269–271.Google Scholar

Takeda, Y: Studies of the metabolism and distribution of fibrinogen in patients with rheumatoid arthritis. J Lab Clin Med 1967;69:624–633.Google Scholar

Jasin, HE, LoSpalluto, J, Ziff, M: Rheumatoid hyperviscosity syndrome. Am J Med 1970;49:484–493.Google Scholar

Alexander, EL, Provost, TT, Stevens, MB, Alexander, GE: Neurologic complications of primary Sjögren’s syndrome. Medicine (Baltimore) 1982;61:247–257.Google Scholar

Alexander, GE, Provost, TT, Stevens, MB, Alexander, EL: Sjögren syndrome: Central nervous system manifestations. Neurology 1981;31:1391–1396.Google Scholar

Alexander, EL, Beall, S, Gordon, B, et al: Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. Ann Intern Med 1988;108:815–823.Google Scholar

Alexander, EL, Malinow, K, Lijewski, JE, et al: Primary Sjögren syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986;104:323–330.Google Scholar

Rubens, E: Scleroderma. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 429–431.Google Scholar

Estey, E, Lieberman, A, Pinto, R, et al: Cerebral arteritis in scleroderma. Stroke 1979;10:595–597.Google Scholar

Pathak, R, Gabor, AJ: Scleroderma and central nervous system vasculitis. Stroke 1991;22:410–413.Google Scholar

Olugemo, O, Stern, BJ: Stroke and neurosarcoidosis. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 75–80.Google Scholar

Newman, LS, Rose, CS, Maier, LA: Sarcoidosis. N Engl J Med 1997;336:1224–1234.Google Scholar

Scott, TF: Neurosarcoidosis: Progress and clinical aspects. Neurology 1993;43:8–12.Google Scholar

Stern, BJ, Krumholz, A, Johns, C, et al: Sarcoidosis and its neurological manifestations. Arch Neurol 1985;42:909–917.Google Scholar

Caplan, LR, Corbett, J, Goodwin, J, et al: Neuro-ophthalmological signs in the angiitic form of neurosarcoidosis. Neurology 1983;33:1130–1135.Google Scholar

Meyer, J, Foley, J, Campagna-Pinto, D: Granulomatous angiitis of the meninges in sarcoidosis. Arch Neurol Psychiatry 1953;69:587–600.Google Scholar

Alajouanine, T, Bertrand, J, Degos, R, et al: Sarcoidose ganglionaire, cutanee et oculaire, avec atteinte secondaire diffuse, peripherique et centrale du système nerveux. Rev Neurol (Paris) 1958;99:421–447.Google Scholar

Urich, H: Neurosarcoidosis or granulomatous angiitis: A problem of definition. Mt Sinai J Med 1977;44:718–725.Google Scholar

Karmi, A: Ophthalmic changes in sarcoidosis. Acta Ophthalmol 1979;141(Suppl):1–94.Google Scholar

Stewart, SS, Ashizawa, T, Dudley, AW Jr, et al: Cerebral vasculitis in relapsing poychondritis. Neurology 1988;38:150.Google Scholar

Thevathasan, AW, Davis, SM: Temporal arteritis. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 9–16.Google Scholar

Melson, MR, Weyland, CM, Newman, NJ, Biousse, V: The diagnosis of giant cell arteritis. Rev Neurol Dis 2007;4:128–142.Google Scholar

Goodwin, J: Temporal arteritis. In Vinken, P, Bruyn, G (eds): Handbook of Clinical Neurology, vol 39, part 2. Amsterdam: North Holland, 1980, pp 313–342.Google Scholar

Klein, RG, Hunder, GG, Stanson, AW, et al: Large artery involvement in giant cell arteritis. Ann Intern Med 1975;83:806–812.Google Scholar

Wilkinson, I, Russel, R: Arteries of the head and neck in giant cell arteritis. Arch Neurol 1972;27:378–391.Google Scholar

Thielen, KR, Wijdicks, EFM, Nichols, DA: Giant cell (temporal) arteritis: Involvement of the vertebral and internal carotid arteries. Mayo Clin Proc 1998;73:444–446.Google Scholar

Enzmann, D, Scott, WR: Intracranial involvement of giant-cell arteritis. Neurology 1977;27:794–797.Google Scholar

Casselli, RJ: Giant cell (temporal) arteritis: A treatable cause of multi-infarct dementia. Neurology 1990;40:753–755.Google Scholar

Schmidt, WA, Kraft, HE, Vorpahl, K, et al: Color Duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997;337:1336–1342.Google Scholar

Zuber, M: Isolated angiitis of the central nervous system. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 1–8.Google Scholar

Salvarani, C, Brown, RD, Calamia, KT, et al: Primary central nervous system vasculitis of 101 patients. Ann Neurol 2007;62:442–451.Google Scholar

Hankey, GJ: Isolated angiitis/angiopathy of the central nervous system. Cerebrovasc Dis 1991;1:2–15.Google Scholar

Kolodny, EH, Rebeiz, JJ, Caviness, VS, Richardson, EP: Granulomatous angiitis of the central nervous system. Arch Neurol 1968;19:510–524.Google Scholar

Vollmer, TL, Guarnaccia, J, Harrington, W, et al: Idiopathic granulomatous angiitis of the central nervous system. Diagnostic challenges. Arch Neurol 1993;50:925–930.Google Scholar

Moore, PM: Diagnosis and management of isolated angiitis of the central nervous system. Neurology 1989;39:167–173.Google Scholar

Burger, PC, Burch, JG, Vogel, FS: Granulomatous angiitis: An unusual etiology of stroke. Stroke 1977;8:29–35.Google Scholar

Harris, KG, Tran, DD, Sickels, WJ, et al: Diagnosing intracranial vasculitis: The role of MR and angiography. AJNR Am J Neuroradiol 1994;15:317–330.Google Scholar

Alhalabi, M, Moore, PM: Serial angiography in isolated angiitis of the central nervous system. Neurology 1994;44:1221–1226.Google Scholar

Shinohara, Y: Takayasu disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 27–32.Google Scholar

Shimizuki, K, Sano, K: Pulseless disease. J Neuropathol Clin Neurol 1951;1:37–47.Google Scholar

Ask-Upmark, E: On the pulseless disease outside of Japan. Acta Med Scand 1954;149:161–178.Google Scholar

Subramanyan, R, Joy, J, Balakrishnan, KG: Natural history of aortoarteritis (Takayasu’s disease). Circulation 1989;80:429–437.Google Scholar

Lupi-Herrera, E, Sanchez-Torres, G, Marcushamer, J, et al: Takayasu’s arteritis: Clinical study of 107 cases. Am Heart J 1977;93:94–103.Google Scholar

Ishikawa, K: Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation 1978;57:27–35.Google Scholar

Sano, K, Alga, T, Saito, I: Angiography in pulseless disease. Radiology 1970;94:69–74.Google Scholar

Hall, S, Barr, W, Lee, JT, et al: Takayasu arteritis: A study of 32 North American patients. Medicine (Baltimore) 1985;54:89–99.Google Scholar

Hargraves, RW, Spetzler, RF: Takayasu’s arteritis: Case report. Barrow Neurol Inst Q 1991;7:20–23.Google Scholar

Kerr, GS, Hallahan, CW, Giordano, J, et al: Takayasu’s arteritis. Ann Intern Med 1994;120:919–929.Google Scholar

Naritomi, H: Takayasu’s arteritis. In Bogousslavsky, J, Caplan, LR (eds): Stroke Syndromes. Cambridge: Cambridge University Press, 1995, pp 437–442.Google Scholar

Klos, K, Flemming, KD, Petty, GW, Luthra HS: Takayasu’s arteritis with arteriographic evidence of intracranial vessel involvement. Neurology 2003;60:1550–1551.Google Scholar

Talwar, KK, Kumar, K, Chopra, P, et al: Cardiac involvement in nonspecific aortoarteritis (Takayasu’s arteritis). Am Heart J 1991;122:1666–1670.Google Scholar

Sun, Y, Yip, P-K, Jeng, J-S, et al: Ultrasonographic study and long-term follow-up of Takayasu’s arteritis. Stroke 1996;27:2178–2182.Google Scholar

Ishikawa, K, Uyama, M, Asayama, K: Occlusive thromboaortopathy (Takayasu’s disease): Cervical occlusive stenosis, retinal artery pressure, retinal microaneurysms and prognosis. Stroke 1983;14:730–735.Google Scholar

Takagi, A, Tada, Y, Sato, O, et al: Surgical treatment for Takayasu’s arteritis: A long-term follow-up study. J Cardiovasc Surg 1989;30:553–558.Google Scholar

Fraga, A, Mintz, G, Valle, L, Flores-Izquierdo, G: Takayasu’s arteritis: Frequency of systemic manifestations (study of 22 patients) and favorable response to maintenance steroid therapy with adrenocorticosteroids (12 patients). Arthritis Rheum 1972;15:617–624.Google Scholar

Biller, J, Asconape, J, Challa, V, et al: A case for cerebral thromboangiitis obliterans. Stroke 1981;12:585–689.Google Scholar

Kumral, E: Behçet’s disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 67–74.Google Scholar

Chajek, T, Fainaro, M: Behçet’s disease: Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975;54:179–195.Google Scholar

Shimizu, T, Ehrlich, GE, Inaba, G, et al: Behçet’s disease (Behçet’s syndrome). Semin Arthritis Rheum 1979;8:223–260.Google Scholar

Wechsler, B, Davatchi, F, Mizushima, Y, et al: Criteria for diagnosis of Behçet’s disease. Lancet 1990;335:1078–1080.Google Scholar

International Study Group for Behçet’s Disease: Evaluation of diagnostic (“classification”) criteria in Behçet’s disease: Towards internationally agreed criteria. Br J Rheum 1992;31:299–308.Google Scholar

Serdaroglu, P, Yazici, H, Ozdemir, C, et al: Neurologic involvement in Behçet’s syndrome: A prospective study. Arch Neurol 1989;46:265–269.Google Scholar

Herskovitz, S, Lipton, RB, Lantos, G: Neuro-Behçet’s disease: CT and clinical correlates. Neurology 1988;38:1714–1720.Google Scholar

Bousser, M-G, Wechsler, B: Behçet’s disease. In Bogousslavsky, J, Caplan, LR (eds): Stroke Syndromes. Cambridge: Cambridge University Press, 1995, pp 460–465.Google Scholar

Al Kawi, MZ, Bohlega, S, Banna, M: MRI findings in neuro-Behçet’s disease. Neurology 1991;41:405–408.Google Scholar

Banna, M, El-Ramahi, K: Neurologic involvement in Behçet’s disease: Imaging findings in 16 patients. AJNR Am J Neuroradiol 1991;12:791–796.Google Scholar

Pamir, MN, Kansu, T, Erbengi, A, Zileli, T: Papilledema in Behçet’s syndrome. Arch Neurol 1981;38:643–645.Google Scholar

Bousser, MG, Chiras, J, Bories, J, Castaigne, P: Cerebral venous thrombosis: A review of 38 cases. Stroke 1985;16:199–213.Google Scholar

Wechsler, B, Vidailhet, M, Piette, JC, et al: Cerebral venous thrombosis in Behçet’s disease: Clinical study and long-term follow-up of 25 cases. Neurology 1992;42:614–618.Google Scholar

Sharief, MK, Hentges, R, Thomas, E: Significance of CSF immunoglobulins in monitoring neurologic disease in Behçet’s disease. Neurology 1991;41:1398–1401.Google Scholar

Cogan, DG: Syndrome of nonsyphilitic interstitial keratitis and vestibulo-auditory symptoms. Arch Ophthalmol 1945;33:144–149.Google Scholar

Calvetti, O, Biousse, V: Cogan’s syndrome. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 259–262.Google Scholar

Cheson, BD, Bluming, AZ, Alroy, J: Cogan’s syndrome: A systemic vasculitis. Am J Med 1976;60:549–555.Google Scholar

Peeters, GJ, Pinckers, AJ, Cremers, CW, Hoefnagels, WH: Atypical Cogan’s syndrome: An autoimmune disease. Ann Otol Rhinol Laryngol 1986;95:173–175.Google Scholar

Romain, PL, Aretz, HT: Case records of the Massachusetts General Hospital: Case 6–1999. N Engl J Med 1999;340:635–641.Google Scholar

Albayram, MS, Wityk, R, Yousem, DM, Zinreich, SJ: The cerebral angiographic findings in Cogan syndrome. AJNR Am J Neuroradiol 2001;22:751–754.Google Scholar

Eales, H: Case of retinal hemorrhage, associated with epistaxis and constipation. Birmingham Med Rev 1880;9:262–273.Google Scholar

Biousse, V: Eales retinopathy. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 235–236.Google Scholar

Biswas, J, Sharma, T, Gopal, L, et al: Eales disease – An update. Surv Ophthalmol 2002;47:197–214.Google Scholar

Miller, NR: Walsh and Hoyt’s Clinical Neuroophthalmology, vol 4, 4th ed. Baltimore: Williams & Wilkins, 1991.Google Scholar

Raizman, MB, Haas, JJ: Case records of the Massachusetts General Hospital: Case 4–1998. N Engl J Med 1998;338:313–319.Google Scholar

Gordon, MF, Coyle, PK, Golub, B: Eales disease presenting as stroke in the young adult. Ann Neurol 1988;24:264–266.Google Scholar

Herson, RN, Squier, M: Retinal perivasculitis with neurological involvement. J Neurol Sci 1978;36:111–117.Google Scholar

Singhal, BS, Dastur, DK: Eales disease with neurological involvement. J Neurol Sci 1976; 27:312–321, 323–345.Google Scholar

White, RH: The etiology and neurological complications of retinal vasculitis. Brain 1961;84:262–273.Google Scholar

Susac, J, Hardman, J, Selhorst, J: Microangiopathy of the brain and retina. Neurology 1979;29:313–316.Google Scholar

Susac, JO: Susac’s syndrome: The triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology 1994;44:591–593.Google Scholar

Papo, T, Biousse, V, Lehoang, P, et al: Susac syndrome. Medicine (Baltimore) 1998;77:3–11.Google Scholar

Henriques, I, Bogousslavsky, J, Caplan, LR: Microangiopathy of the retina, inner ear, and brain: Susac’s syndrome. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 247–254.Google Scholar

Petty, G, Engel, A, Younge, BR, et al: Retinocochleocerebral vasculopathy. Medicine (Baltimore) 1998;77:122–140.Google Scholar

Coppeto, J, Currie, J, Monteiro, M, et al: A syndrome of arterial-occlusive retinopathy and encephalopathy. Am J Ophthalmol 1984;98:189–202.Google Scholar

Swanson, R, Mario, L, Monteiro, M, et al: A microangiopathic syndrome of encephalopathy, hearing loss and retinal artery occlusion. Neurology 1985;35(Suppl 1):145.Google Scholar

Bogousslavsky, J, Gaio, JM, Caplan, LR, et al: Encephalopathy, deafness, and blindness in young women: A distinct retino-cochleo-cerebral arteriolopathy. J Neurol Neurosurg Psychiatry 1989;52:43–46.Google Scholar

Reichhart, M: Acute posterior multifocal placoid pigment epitheliopathy (APMPPE). In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 237–246.Google Scholar

Gass, JDM: Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1968;80:177–185.Google Scholar

Gass, JD: Acute posterior multifocal placoid pigment epitheliopathy. Retina 2003;23:177–185.Google Scholar

Jones, NP: Acute posterior multifocal placoid pigment epitheliopathy. Br J Ophthalmol 1995;79:384–389.Google Scholar

Comu, S, Verstraeten, T, Rinkoff, JS, Busis, NA: Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke 1996;27:996–1001.Google Scholar

Smith, CH, Savino, PJ, Beck, RW, et al: Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. Arch Neurol 1983;40:48–50.Google Scholar

Weinstein, JM, Bresnick, GH, Bell, CL, et al: Acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis. J Clin Neuroophthalmol 1988;8:195–201.Google Scholar

Bewermeyer, H, Nelles, G, Huber, M, et al: Pontine infarction in acute posterior multifocal placoid pigment epitheliopathy. J Neurol 1993;241:22–26.Google Scholar

Wilson, CA, Choromokos, EA, Sheppard, R: Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. Arch Ophthalmol 1988;106:796–800.Google Scholar

Manor, RS: Vogt–Koyanagi–Harada syndrome and related diseases. In Vinken, P, Bruyn, G, Klawans, H (eds): Handbook of Clinical Neurology, vol 34, part 2. Amsterdam: North Holland, 1978, pp 513–544.Google Scholar

Andreoli, CM, Foster, CS: Vogt–Koyanagi–Harada disease. Int Ophthalmol Clin 2006;46:111–122.Google Scholar

Kato, Y, Kurimura, M, Yahata, Y, et al: Vogt–Koyanagi–Harada’s disease presenting polymorphonuclear pleocytosis in the cerebrospinal fluid at the early active stage. Intern Med 2006;45:779–781.Google Scholar

Khoury, T, Gonzalez-Fernandez, F, Munschauer, FE 3rd, Ostrow, P: A 47-year-old man with sudden onset of blindness, pleocytosis, and temporary hearing loss. Vogt–Koyanagi–Harada syndrome (Uveomeningoencephalitic syndrome). Arch Pathol Lab Med 2006;130:1070–1072.Google Scholar

De Reuck, JL, De Bleecker, JL: Sneddon’s syndrome. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 405–412.Google Scholar

Sneddon, B: Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965;77:180–185.Google Scholar

Tourbah, A, Piette, JC, Iba-Zizen, MT, et al: The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol 1997;54:53–60.Google Scholar

Thomas, DJ, Kirby, JD, Britton, KE, Galton, DJ: Livedo reticularis and neurological lesions. Br J Dermatol 1982;106:711–712.Google Scholar

Rebollo, M, Val, JF, Garijo, F, et al: Livedo reticularis and cerebrovascular lesions (Sneddon’s syndrome). Brain 1983;106:965–979.Google Scholar

Stockhammer, G, Felber, SR, Zelger, B, et al: Sneddon syndrome: Diagnosis by skin biopsy and MRI in 17 patients. Stroke 1993;24:685–690.Google Scholar

Pettee, AD, Wasserman, BA, Adams, NL, et al: Familial Sneddon’s syndrome: Clinical, hematologic, and radiographic findings in two brothers. Neurology 1994;44:399–405.Google Scholar

Levine, SR, Langer, SL, Albers, JW, Welch, KMA: Sneddon’s syndrome: An antiphospholipid antibody syndrome? Neurology 1988;38:798–800.Google Scholar

Cornett, O, Rosenbaum, DH: Kohlmeier–Degos disease (malignant atrophic papulosis). In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 377–380.Google Scholar

Caviness, VS Jr, Sagar, P, Israel, EJ, et al: Case 38–2006: A 5-year-old boy with headache and abdominal pain. N Engl J Med 2006;355:2575–2584.Google Scholar

Petit, WA, Soso, MJ, Higman, H: Degos disease: Neurologic complications and cerebral angiography. Neurology 1982;32:1305–1309.Google Scholar

Strole, WE, Clark, WH, Isselbacher, KJ: Progressive arterial occlusive disease (Kohlmeier–Degos). N Engl J Med 1967;276:195–201.Google Scholar

Subbiah, P, Wijdicks, E, Muenter, M, et al: Skin lesion with a fatal neurologic outcome (Degos’ disease). Neurology 1996;46:636–640.Google Scholar

Caplan, LR: Drugs. In Kase, CS, Caplan, LR (eds): Intracerebral Hemorrhage. Boston: Butterworth–Heinemann, 1994, pp 201–220.Google Scholar

Brust, JC: Stroke and substance abuse. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 365–370.Google Scholar

Brust, J, Richter, R: Stroke associated with addiction to heroin. J Neurol Neurosurg Psychiatry 1978;39:194–199.Google Scholar

Woods, B, Strewler, G: Hemiparesis occurring six hours after intravenous heroin injection. Neurology 1972;22:863–866.Google Scholar

Caplan, LR, Hier, DB, Banks, G: Current concepts in cerebrovascular disease – stroke: Stroke and drug abuse. Stroke 1982;13:869–872.Google Scholar

Brust, JC: Stroke and drugs. In Vinker, P, Bruyn, G, Klawans, H (eds): Handbook of Clinical Neurology, vol 11. Amsterdam: Elsevier, 1989, pp 517–531.Google Scholar

Pearson, J, Richter, R: Addiction to opiates: Neurologic aspects. In Vinken, P, Bruyn, G (eds): Handbook of Clinical Neurology, vol 37. Amsterdam: North Holland, 1979, pp 365–400.Google Scholar

Citron, B, Halpern, M, McCarron, M, et al: Necrotizing angiitis associated with drug abuse. N Engl J Med 1970;283:1003–1011.Google Scholar

Rumbaugh, C, Bergeron, R, Gang, H, et al: Cerebral vascular changes secondary to amphetamine abuse in the experimental animal. Radiology 1971;101:345–351.Google Scholar

Rumbaugh, C, Bergeron, R, Gang, H, et al: Cerebral angiographic changes in the drug abuse patient. Radiology 1971;101:335–344.Google Scholar

Caplan, LR, Thomas, C, Banks, G: Central nervous system complications of “T’s and Blues” addiction. Neurology 1982;32:623–628.Google Scholar

Szwed, JJ: Pulmonary angiothrombosis caused by “blue velvet” addiction. Ann Intern Med 1970;73:771–774.Google Scholar

Atlee, W: Talc and cornstarch emboli in the eyes of drug abusers. JAMA 1972;219:49–51.Google Scholar

Mizutami, T, Lewis, R, Gonatas, N: Medial medullary syndrome in a drug abuser. Arch Neurol 1980;37:425–428.Google Scholar

Schoenberger, SD, Agarwal, A: Talc retinopathy. N Engl J Med 2013;368:852.Google Scholar

Kaku, D, Lowenstein, DH: Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med 1990;133:821–827.Google Scholar

Levine, SR, Welch, KM: Cocaine and stroke: Current concepts of cardiovascular disease. Stroke 1988;19:779–783.Google Scholar

Daras, M, Tuchman, AJ, Marks, S: Central nervous system infarction related to cocaine abuse. Stroke 1991;22:1320–1325.Google Scholar

Levine, SR, Washington, JM, Jefferson, ME, et al: “Crack” cocaine-associated stroke. Neurology 1987;37:1849–1853.Google Scholar

Levine, SR, Brust, JC, Futrell, N, et al: A comparative study of the cerebrovascular complications of cocaine-alkaloidal versus hydrochloride – a review. Neurology 1991;41:1173–1177.Google Scholar

Rowley, HA, Lowenstein, DH, Rowbotham, MC, Simon, RP: Thalamomesencephalic strokes after cocaine abuse. Neurology 1989;39:428–430.Google Scholar

Di Lazzaro, V, Restuccia, D, Oliviero, A, et al: Ischaemic myelopathy associated with cocaine: Clinical, neurophysiological, and neuroradiological features. J Neurol Neurosurg Psychiatry 1997;63:531–533.Google Scholar

Isner, JM, Estes, NA, Thompson, PD, et al: Acute cardiac events temporally related to cocaine. N Engl J Med 1986;315:1438–1443.Google Scholar

Brust, JCM: Neurological Aspects of Substance Abuse, 2nd ed. Boston: Butterworth–Heinemann, 2004.Google Scholar

Kaufman, MJ, Levin, JM, Ross, MH, et al: Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 1998;279:376–380.Google Scholar

Nolte, KB, Brass, LM, Fletterick, CF: Intracranial hemorrhage associated with cocaine abuse: A prospective study. Neurology 1996;46:1291–1296.Google Scholar

Savitz, S, Caplan, LR: Migraine and migraine-like conditions. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 529–531.Google Scholar

Singhal, AB, Koroshetz, WF, Caplan, LR: Reversible cerebral vasoconstriction syndromes. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 505–514.Google Scholar

Caplan, LR: Migraine in Posterior Circulation Disease: Diagnosis, Clinical Findings, and Management. Boston: Blackwell Science, 1996.Google Scholar

Kruit, MC, van Buchem, MA, Hofman, PA, et al: Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427–434.Google Scholar

Rothrock, JF, Walicke, P, Swendon, M, et al: Migrainous stroke. Arch Neurol 1988;45:63–67.Google Scholar

Bogousslavsky, J, Regli, F, Van Melle, G, et al: Migraine stroke. Neurology 1988;38:223–227.Google Scholar

Caplan, LR: Migraine and vertebrobasilar ischemia. Neurology 1991;41:55–61.Google Scholar

Rothrock, J, North, J, Madden, K, et al: Migraine and migrainous stroke: Risk factors and prognosis. Neurology 1993;43:2473–2476.Google Scholar

Henrich, JB, Horwitz, RI: A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 1989;42:773–780.Google Scholar

Stang, PE, Carson, AP, Rose, KM, et al: Headache, cerebrovascular symptoms, and stroke: The Atherosclerosis Risk in Communities Study. Neurology 2005;64:1573–1577.Google Scholar

Etminan, M, Takkouche, B, Isorna, FC, Samii, A: Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ 2005;330:63.Google Scholar

Donaghy, M, Chang, CL, Poulter, N: European Collaborators of The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002;73:747–750.Google Scholar

Solomon, S, Lipton, RB, Harris, PY: Arterial stenosis in migraine: Spasm or arteriopathy? Headache 1990;30:52–61.Google Scholar

Pessin, MS, Lathi, ES, Cohen, MB, et al: Clinical features and mechanisms of occipital infarction in the posterior cerebral artery territory. Ann Neurol 1987;21:290–299.Google Scholar

Fisher, CM: Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980;7:9–17.Google Scholar

Fisher, CM: Late-life migraine accompaniments: Further experience. Stroke 1986;17:1033–1042.Google Scholar

Wijman, CAC, Wolf, PA, Kase, CS, et al: Migrainous visual accompaniments are not rare in late life. The Framingham Study. Stroke 1998;29:1539–1543.Google Scholar

Caplan, LR, Chedru, F, Lhermitte, F, Mayman, C: Transient global amnesia and migraine. Neurology 1981;31:1167–1170.Google Scholar

Caplan, LR: Transient global amnesia: Characteristic features and overview. In Markowitsch, HJ (ed): Transient Global Amnesia and Related Disorders. Toronto: Hogrife and Huber, 1990, pp 15–27.Google Scholar

Call, GK, Fleming, MC, Sealfon, S, et al: Reversible cerebral segmental vasoconstriction. Stroke 1988;19:1159–1170.Google Scholar

Bogousslavsky, J, Despland, PA, Regli, F, Dubuis, PY: Postpartum cerebral angiopathy: Reversible vasoconstriction assessed by transcranial Doppler ultrasound. Eur Neurol 1989;29:102–105.Google Scholar

Chen, S-P, Fuh, J-L, Lirng, J-F, et al: Recurrent primary thunderclap headache and benign CNS angiopathy. Neurology 2006;67:2164–2169.Google Scholar

Ducros, A, Boukobza, M, Porcher, R, et al: The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007;130:3091–3101.Google Scholar

Lopez-Valdes, E, Chang, H-M, Pessin, MS, Caplan, LR: Cerebral vasoconstriction after carotid surgery. Neurology 1997;49:303–304.Google Scholar

Calabrese, LH, Dodick, DW, Schwedt, TJ, et al: Narrative reviews: Reversible cerebral vasoconstriction syndrome. Ann Intern Med. 2007;146:34–44.Google Scholar

Moustafa, RR, Allen, CMC, Baron, J-C: Call–Fleming syndrome associated with subarachnoid haemorrhage: Three new cases. J Neurol Neurosurg Psychiatry 2008;79:602–605.Google Scholar

Ducros, A: Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906–917.Google Scholar

French, KF, Hoesch, RE, Allred, J, et al: Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome. J Clin Neurosci 2012;19:174–76.Google Scholar

Bartleson, JD, Swanson, JW, Whisnant, JP: A migrainous syndrome with cerebrospinal fluid pleocytosis. Neurology 1981;31:1257–1262.Google Scholar

Gomez-Aranda, F, Canadillas, F, Marti-Masso, JF, et al: Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain 1997;120:1105–1113.Google Scholar

Martin-Balbuena, S, Arpa-Gutierrez, FJ: Pseudomigraine with cerebrospinal fluid pleocytosis or syndrome of headache, temporary neurological deficit and cerebrospinal fluid. A historical review. Rev Neurol 2007;45:624–630.Google Scholar

Emond, H, Schnorf, H, Poloni, C, Vulliemoz, S, Lalive, PH: Syndrome of transient headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with recent human herpesvirus-6 infection. Cephalalgia. 2009;29:487–491.Google Scholar

Black, DF, Bartleson, JD, Bell, ML, Lachner, DH: SMART: Stroke-like migraine attacks after radiation therapy. Cephalgia 2006;26:1137–1142.Google Scholar

Pruitt, A, Dalmau, J, Detre, J, et al: Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology 2006;67:676–678.Google Scholar

Black, DF, Morris, JM, Lindell, EP, et al: Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible: A case series. Am J Neuroradiol 2013;36:1–6.Google Scholar

Wang, N, Prasad, S: SMART syndrome. Stroke-like migraine attacks after radiation therapy. Neurol Clin Pract 2014;1:530–531.Google Scholar

Cole, AJ, Aube, M: Migraine with vasospasm and delayed intracerebral hemorrhage. Arch Neurol 1990;47:53–56.Google Scholar

Gautier, JC, Majdalani, A, Juillard, JB, et al: Hemorragies cerebrales au cours de la migraine. Rev Neurol (Paris) 1993;149:407–410.Google Scholar

Caplan, LR: Intracerebral hemorrhage revisited. Neurology 1988;38:624–627.Google Scholar

Digre, K, Varner, M, Caplan, LR: Eclampsia and stroke during pregnancy and the puerperium. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 515–528.Google Scholar

Siderov, E, Feng, W, Caplan, LR: Stroke in pregnant and postpartum women. Expert Rev Cardiovasc Ther 2011;9:1235–1247.Google Scholar

Edlow, JA, Caplan, LR, O’Brien, K, Tibbles, C: Diagnosis of acute neurological emergencies in pregnant and postpartum women. Lancet Neurol 2013;12:175–185.Google Scholar

Hoffmann, M, Keiseb, J, Moodley, J, Corr, P: Appropriate neurological evaluation and multimodality magnetic resonance imaging in eclampsia. Acta Neurol Scand 2002;106:159–167.Google Scholar

Neudecker, S, Stock, K, Krasnianski, M: Call–Fleming postpartum angiopathy in the puerperium: A reversible cerebral vasoconstriction syndrome. Obstet Gynecol 2006;107:446–449.Google Scholar

Duncan, R, Hadley, D, Bone, I, et al: Blindness in eclampsia: CT and MR imaging. J Neurol Neurosurg Psychiatry 1998;52:899–902.Google Scholar

Easton, JD, Mas, J-L, Lamy, C, et al: Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy? Cerebrovasc Dis 1998;8:53–58.Google Scholar

Hinchey, J, Chaves, C, Appignani, B, et al: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.Google Scholar

Schwartz, RB, Feske, SK, Polak, JF, et al: Preeclampsia-eclampsia: Clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000;217:371–376.Google Scholar

Hinchey, JA: Reversible leukoencephalopathy syndrome: what have we learned in the past 10 years. Arch Neurol 2008;65:175–176.Google Scholar

Adams, H, Davis, P, Hennerici, M: Moyamoya. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 465–478.Google Scholar

Suzuki, J, Kodama, N: Moyamoya disease – a review. Stroke 1983;14:104–109.Google Scholar

Suzuki, J: Moyamoya Disease. Berlin: Springer, 1986.Google Scholar

Kuroda, S, Hashimoto, N, Yoshimoto, T, et al: Radiological findings, clinical course, and outcome in aymptomatic moyamoya disease. Stroke 2007;38:1430–1435.Google Scholar

Chiu, D, Shedden, P, Bratina, P, Grotta, JC: Clinical features of moyamoya disease in the United States. Stroke 1998;29:1347–1351.Google Scholar

Taveras, JM: Multiple progressive intracranial arterial occlusions: A syndrome of children and young adults. AJR Am J Roentgenol 1969;106:235–268.Google Scholar

Bruno, A, Adams, HOP, Bilbe, J, et al: Cerebral infarction due to moyamoya disease in young adults. Stroke 1988;19:826–833.Google Scholar

Mauro, AJ, Johnson, ES, Chikos, PM, Alvord, EC: Lipohyalinosis and miliary microaneurysms causing cerebral hemorrhage in a patient with moyamoya. A clinicopathological study. Stroke 1980;11:405–412.Google Scholar

Ikeda, E: Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke 1991;22:1358–1362.Google Scholar

Southerland, AM, Meschia, JF, Worrall, BB: Shared associations of nonatherosclerotic, large-vessel, cerebrovascular arteriopathies: Considering intracranial aneurysms, cervical artery dissection, moyamoya disease and fibromuscular dysplasia. Curr Opin Neurol 2013;26:13–28.Google Scholar

Ueki, K, Meyer, FB, Mellinger, JF: Moyamoya disease: The disorder and surgical treatment. Mayo Clin Proc 1994;69:749–757.Google Scholar

Herreman, F, Nathal, E, Yasui, N, Yonekawa, Y: Intracranial aneurysms in moyamoya disease: Report of ten cases and review of the literature. Cerebrovasc Dis 1994;4:329–336.Google Scholar

Robertson, RL, Burrows, PE, Barnes, PD, et al: Angiographic changes after pial synangiosis in childhood moyamoya disease. AJNR Am J Neuroradiol 1997;18:837–845.Google Scholar

Houkin, K, Kamiyama, H, Abe, H, et al: Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 1996;27:1342–1346.Google Scholar

Smith, ER, Scott, RM: Surgical management of moyamoya syndrome. Skull Base 2005;15:15–26.Google Scholar

Scott, RM, Smith, ER: Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226–1237.Google Scholar

Kamada, F, Aoki, Y, Narisawa, A, et al: A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 2011;56:34–40.Google Scholar

Liu, W, Morito, D, Takashima, S, et al: Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22542.Google Scholar

Hart, RG, Kanter, MC: Hematologic disorders and ischemic stroke: A selective review. Stroke 1990;21:1111–1121.Google Scholar

Markus, HS, Hambley, H: Neurology and the blood: Haematological abnormalities in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998;64:150–159.Google Scholar

Adams, RJ: Big strokes in small persons. Arch Neurol 2007;64:1567–1574.Google Scholar

Switzer, JA, Hess, DC, Nichols, FT, Adams, RJ: Pathophysiology and treatment of stroke in sickle-cell disease: Present and future. Lancet 2006;5:501–512.Google Scholar

Rothman, SM, Fulling, KH, Nelson, JS: Sickle cell anemia and central nervous system infarction: A neuropathological study. Ann Neurol 1986;20:684–690.Google Scholar

Adams, RJ, Nichols, FT, McKie, V, et al: Cerebral infarction in sickle cell anemia: mechanisms based on CT and MRI. Neurology 1988;38:1012–1017.Google Scholar

Steen, RG, Langston, JW, Ogg, RJ, et al: Ectasia of the basilar artery in children with sickle cell disease: Relationship to hematocrit and psychometric measures. J Stroke Cerebrovasc Dis 1998;7:32–43.Google Scholar

Oguz, M, Aksungur, EH, Soyupak, SK, Yildirim, AU: Vein of Galen and sinus thrombosis with bilateral thalamic infarcts in sickle cell anemia: CT follow-up and angiographic demonstration. Neuroradiology 1994;36:155–156.Google Scholar

Adams, RJ: TCD in sickle-cell disease: An important and useful test. Pediatr Radiol 2005;35:229–234.Google Scholar

Adams, RJ, McKie, VC, Hsu, L, et al: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5–11.Google Scholar

Hillmen, P, Lewis, SM, Bessler, M, et al: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253–1258.Google Scholar

Ziakas, PD, Poulou, LS, Rokas, GI, et al: Thrombosis in paroxysmal nocturnal hemoglobinuria: Sites, risks, outcome. An overview. J Thromb Haemost 2007;5:642–645.Google Scholar

Poulou, LS, Vakrinos, G, Pomoni, A, et al: Stroke in paroxysmal nocturnal haemoglobinuria: Patterns of disease and outcome. Thromb Haemost 2007;98:699–701.Google Scholar

Murphy, S, Iland, H, Rosenthal, D, Laszlo, J: Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group. Semin Hematol 1986;23:177–182.Google Scholar

Jabaily, J, Iland, HJ, Laszlo, J, et al: Neurologic manifestations of essential thrombocythemia. Ann Intern Med 1983;99:513–518.Google Scholar

Hehlmann, R, Jahn, M, Baumann, B, Kopcke, W: Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 1988;61:2487–2496.Google Scholar

Arboix, A, Besses, C, Acin, P, et al: Ischemic stroke as the first manifestation of essential thrombocythemia. Stroke 1995;26:1463–1466.Google Scholar

Ogata, J, Yonemura, K, Kimura, Y, et al: Cerebral infarction associated with thrombocythemia: An autopsy case study. Cerebrovasc Dis 2005;19:201–205.Google Scholar

Wu, K: Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med 1978;88:7–11.Google Scholar

Al-Mefty, O, Marano, G, Rajaraman, S, et al: Transient ischemic attacks due to increased platelet aggregation and adhesiveness. J Neurosurg 1979;50:449–453.Google Scholar

Trip, MD, Cats, VM, van Capelle, FJL, Vreeken, J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549–1554.Google Scholar

Védy, D, Schapira, M, Angelillo-Scherrer, A: Bleeding disorders and thrombophilia. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 283–300.Google Scholar

Thaler, E, Lechner, K: Antithrombin III deficiency and thromboembolism. Clin Haematol 1981;10:369–390.Google Scholar

Camerlingo, M, Finazzi, G, Casto, L, et al: Inherited protein C deficiency and nonhemorrhagic arterial stroke in young adults. Neurology 1991;41:1371–1373.Google Scholar

Dahlback, B, Carlsson, M, Svensson, PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993;90:1004–1008.Google Scholar

Zoller, B, Dahlback, B: Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994;343:1536–1538.Google Scholar

Ridker, PM, Miletich, JP, Stampfer, MJ, et al: Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 1997;95:1777–1782.Google Scholar

Poort, SR, Rosendaal, FR, Reitsma, PH, Bertina, RM: A common genetic variation in the 3’ untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698–3703.Google Scholar

Huberfeld, G, Kubis, N, Lot, G, et al: G20210A Prothrombin gene mutation in two siblings with cerebral venous thrombosis. Neurology 1998;51:316–317.Google Scholar

Martinelli, I, Sacchi, E, Landi, G, et al: High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793–1797.Google Scholar

Estol, C, Pessin, MS, DeWitt, LD, Caplan, LR: Stroke and increased factor VIII activity. Neurology 1989;39(suppl 1):1159.Google Scholar

Kosik, KS, Furie, B: Thrombotic stroke associated with elevated factor VIII. Arch Neurol 1980;8:435–437.Google Scholar

De Georgia, MA, Rose, DZ: Stroke in patients who have inflammatory bowel disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 381–386.Google Scholar

Talbot, RW, Heppell, J, Dozois, RR, Beart, RW: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140–145.Google Scholar

Johns, DR: Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol 1991;86:367–370.Google Scholar

Sigsbee, B, Rottenberg, DA: Sagittal sinus thrombosis as a complication of regional enteritis. Ann Neurol 1978;3:450–452.Google Scholar

Grau, A, Buggle, F, Heindl, S, et al: Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995;26:373–379.Google Scholar

Syrjanen, J, Valtonen, VV, Iivanainen, M, et al: Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. BMJ 1988;296:1156–1160.Google Scholar

Grau, A, Buggle, F, Steichen-Wiehn, C, et al: Clinical and histochemical analysis in infection-associated stroke. Stroke 1995;26:1520–1526.Google Scholar

Grau, A: Infection, inflammation, and cerebrovascular ischemia. Neurology 1997;49(suppl 4):S47–S51.Google Scholar

Leira, R, Davalos, A, Castillo, J: Cancer and paraneoplastic strokes. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 371–376.Google Scholar

Sack, GH, Levin, J, Bell, WR: Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms. Medicine (Baltimore) 1977;56:1–37.Google Scholar

Graus, F, Rodgers, LR, Posner, JB: Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985;64:16–35.Google Scholar

Amico, L, Caplan, LR, Thomas, C: Cerebrovascular complications of mucinous cancers. Neurology 1989;39:523–526.Google Scholar

Kablau, M, Michael, G, Hennerici, MG, Marc Fatar, M, et al: Stroke and cancer: The importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke 2012;43:3029–3034.Google Scholar

Hajjar, K, Francis, CW: Fibrinolysis and thrombolysis. In Lichtman, MA, Beutler, E, Kipps, TJ, Seligsohn, U, Kaushansky, K, Prchal, JT (eds): Williams Hematology, 7th ed. New York: McGraw-Hill, 2006, pp 2089–2115.Google Scholar

Sloane, MA: Thrombolysis and stroke – past and future. Arch Neurol 1986;44:748–768.Google Scholar

Del Zoppo, GH, Zeumer, H, Harker, LA: Thrombolytic therapy in stroke: Possibilities and hazards. Stroke 1986;17:595–607.Google Scholar

Francis, RB: Clinical disorders of fibrinolysis. Blut 1989;59:1–14.Google Scholar

Nilsson, IM, Ljungner, H, Tengborn, L: Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentrations of plasminogen activator or increased concentration of plasminogen activator inhibitor. BMJ 1985;290:1453–1456.Google Scholar

Collen, D, Lijnen, HR: The fibrinolytic system in man. Crit Rev Oncol Hematol 1986;4:249–301.Google Scholar

Nagayama, T, Shinohara, Y, Nagayama, M, et al: Congenitally abnormal plasminogen in juvenile ischemic cerebrovascular disease. Stroke 1993;24:2104–2107.Google Scholar

Hunt, FA, Rylatt, DB, Hart, R, Bundesen, PG: Serum cross-linked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems. Br J Haematol 1985;60:715–722.Google Scholar

Feinberg, WM, Bruck, DC, Ring, ME, Corrigan, JJ: Hemostatic markers in acute stroke. Stroke 1989;20:582–587.Google Scholar

Delgado, J, Jimenez-Yuste, V, Hernandez-Navarro, F, Villar, A: Acquired hemophilia. Review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003;121:21–35.Google Scholar

Johansen, RF, Sorensen, B, Ingerslev, J: Acquired haemophilia: Dynamic whole blood coagulation utilized to guide haemostatic therapy. Haemophilia 2006;12:190–197.Google Scholar

Ruggeri, ZM, Zimmerman, TS: von Willebrand factor and von Willebrand disease. Blood 1987;70:895–904.Google Scholar

Wilde, JT: Von Willebrand disease. Clin Med 2007;7:629–632.Google Scholar

Nurden, P, Nurden, AT: Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008;99:253–263.Google Scholar

Roldan, J, Brey, RL: Antiphospholipid antibody syndrome. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 263–274.Google Scholar

Levine, SR, Welch, KMA: Cerebrovascular ischemia associated with lupus anticoagulant. Stroke 1987;18:257–263.Google Scholar

DeWitt, LD, Caplan, LR: Antiphospholipid antibodies and stroke. AJNR Am J Neuroradiol 1991;12:454–456.Google Scholar

Cervera, R, Piette, JC, Font, J, et al: Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019–1027.Google Scholar

Coull, BM, Goodnight, SH: Antiphospholipid antibodies, prethrombotic states, and stroke. Stroke 1990;21:1370–1374.Google Scholar

Levine, SR, Kim, S, Deegan, MI, Welch, KMA: Ischemic stroke associated with anticardiolipin antibodies. Stroke 1987;18:1101–1106.Google Scholar

Montalban, J, Codina, A, Ordi, J, et al: Antiphospholipid antibodies in cerebral ischemia. Stroke 1991;22:750–753.Google Scholar

Pope, JM, Canny, CL, Bell, DA: Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med 1991;90:299–309.Google Scholar

Antiphospholipid Antibodies in Stroke Study (APASS) Group: Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990;21:1268–1273.Google Scholar

Lopez, LR, Dier, KJ, Lopez, D, et al: Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004;121:142–149.Google Scholar

Atsumi, T, Ieko, M, Bertolaccini, ML, et al: Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presense of lupus anticoagulant. Arthritis Rheum 2000;43:1982–1993.Google Scholar

Feldmann, E, Levine, SR: Cerebrovascular disease with antiphospholipid antibodies: Immune mechanisms, significance, and therapeutic options. Ann Neurol 1995;37(suppl 1):S114–S130.Google Scholar

Levine, SR, Salowich-Palm, L, Sawaya, KL, et al: IgG anticardiolipin antibody titer 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke 1997;28:1660–1665.Google Scholar

Verro, P, Levine, SR, Tietjen, GE: Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 1998;29:2245–2253.Google Scholar

Provenzale, JM, Barboriak, DP, Allen, NB, Ortel, TL: Antiphospholipid antibodies: Findings at arteriography. AJNR Am J Neuroradiol 1998;19:611–616.Google Scholar

Bick, RL: Disseminated intravascular coagulation and related syndromes: A clinical review. Semin Thromb Hemost 1988;14:299–338.Google Scholar

Wen, PY, Sobel, RA: Case records of the Massachusetts General Hospital: Case 36–1991. N Engl J Med 1991;325:714–726.Google Scholar

Colman, RW, Rubin, RN: Disseminated intravascular coagulation due to malignancy. Semin Oncol 1990;17:172–186.Google Scholar

Schwartzman, RJ, Hill, JB: Neurologic complications of disseminated intravascular coagulation. Neurology 1982;32:791–797.Google Scholar

Schwartzman, RJ, Kumar, M: Disseminated intravascular disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 275–282.Google Scholar

Dashe, J: Hyperviscosity and stroke. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 347–356.Google Scholar

Grotta, J, Ackerman, R, Correia, J, et al: Whole blood viscosity parameters and cerebral blood flow. Stroke 1982;13:296–301.Google Scholar

Coull, BM, Beamer, N, de Garmo, P, et al: Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke 1991;22:162–168.Google Scholar

Ernst, E, Resch, KL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 1993;118:956–963.Google Scholar

Fahey, JL, Barth, WF, Solomon, A: Serum hyperviscosity syndrome. JAMA 1965;192:464–467.Google Scholar

Rosenson, RS, Baker, AL, Chow, M, Hay, R: Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology 1990;98:1351–1357.Google Scholar

Fauci, A, Haynes, BF, Costa, J, et al: Lymphatoid granulomatosis: Prospective clinical and therapeutic experience over 10 years. N Engl J Med 1982;306:68–74.Google Scholar

Hogan, PJ, Greenberg, MK, McCarty, GE: Neurologic complications of lymphomatoid granulomatosis. Neurology 1981;31:619–620.Google Scholar

Hochberg, EP, Gilman, MD, Hasserjian, RP: Case records of the Massachusetts General Hospital. Case 17–2006 – a 34-year-old man with cavitary lung lesions. N Engl J Med 2006;354:2485–2493.Google Scholar

Mizuno, T, Takanashi, Y, Onodera, H, et al: A case of lymphomatoid granulomatosis/angiocentric immunoproliferative lesion with long clinical course and diffuse brain involvement. J Neuro Sci 2003;213:67–76.Google Scholar

Rubens, EO: Intravascular lymphoma. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 533–537.Google Scholar

Petito, CK, Gottlieb, GJ, Dougherty, JH, Petito, FA: Neoplastic angioendotheliosis: Ultrastructural study and review of the literature. Ann Neurol 1978;3:393–399.Google Scholar

Beal, MF, Fisher, CM: Neoplastic angioendotheliosis. J Neurol Sci 1982;53:359–375.Google Scholar

Reinglass, JL, Miller, J, Wissman, S: Central nervous system angioendotheliosis. Stroke 1977;8:218–221.Google Scholar

Raroque, HG, Mandler, RN, Griffey, MS, et al: Neoplastic angioendotheliomatosis. Arch Neurol 1990;47:929–930.Google Scholar

Glass, J, Hochberg, FH, Miller, DC: Intravascular lymphomatosis – a systemic disease with neurologic manifestations. Cancer 1993;71:3156–3164.Google Scholar

Hamada, K, Hamada, T, Satoh, M, et al: Two cases of neoplastic angioendotheliomatosis presenting with myelopathy. Neurology 1991;41:1139–1140.Google Scholar

Kanegane, H, Ito, Y, Ohshima, K, et al: X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis. Am J Hematol 2005;78:130–133.Google Scholar

Natowicz, M, Kelley, RI: Mendelian etiologies of stroke. Ann Neurol 1987;22:175–192.Google Scholar

Albert, M: Genetics of Cerebrovascular Disease. Armonk, NY: Futura, 1999.Google Scholar

Alberts, MJ: Genetics of cerebrovascular disease. Stroke 2004;35:342–344.Google Scholar

Meschia, JF, Worrall, BB: New advances in identifying genetic anomalies in stroke-prone probands. Curr Neurol Neurosci Rep 2004;4:420–426.Google Scholar

Hoy, A, Leininger-Muller, B, Poirier, O, et al: Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. Atherosclerosis 2003;167:223–230.Google Scholar

Hirt, L: MELAS and other mitochondrial disorders. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 149–154.Google Scholar

Pavlakis, SG, Phillips, PC, DiMauro, S, et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: A distinctive clinical syndrome. Ann Neurol 1984;16:481–488.Google Scholar

Morgan-Hughes, JA: Mitochondrial diseases. In Engel, AG, Franzini-Armstrong, C (eds): Myology, vol 2, 2nd ed. New York: McGraw-Hill, 1994, pp 1610–1660.Google Scholar

Kuriyama, M, Umezaki, H, Fukuda, Y, et al: Mitochondrial encephalomyopathy with lactate-pyruvate elevation and brain infarctions. Neurology 1984;34:72–77.Google Scholar

Allard, JC, Tilak, C, Carter, AP: CT and MR of MELAS syndrome. AJNR Am J Neuroradiol 1988;9:1234–1238.Google Scholar

Koo, B, Becker, LE, Chuang, S, et al: Mitochondrial encephalomyopathy, lactic acidosis, stroke like episodes (MELAS): Clinical, radiological, and genetic observations. Ann Neurol 1993;34:25–32.Google Scholar

Matthews, PM, Tampieri, D, Berkovic, SF, et al: Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991;41:1043–1046.Google Scholar

Clark, JM, Marks, MP, Adalsteinsson, E, et al: MELAS: Clinical and pathological correlations with MRI, Xenon/CT, and MR spectroscopy. Neurology 1996;46:223–227.Google Scholar

Sue, CM, Crimmins, DS, Soo, YS, et al: Neuroradiological features of six kindreds with MELAS tRNALeu A3243 G point mutation: Implications for pathogenesis. J Neurol Neurosurg Psychiatry 1998;65:233–240.Google Scholar

Mitsias, P, Levine, SR: Cerebrovascular complications of Fabry’s disease. Ann Neurol 1996;40:8–17.Google Scholar

Mitsias, P, Papamitsakis, NIH, Amory, CF, Levine, SR: Cerebrovascular complications of Fabry disease. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 123–130.Google Scholar

Brady, RO, Gal, AE, Bradley, RM, et al: Enzymatic defect in Fabry’s disease: Ceramide trihexosidase deficiency. N Engl J Med 1967;276:1163–1167.Google Scholar

Dawson, DM, Miller, DC: Case records of the Massachusetts General Hospital: Case 2–1984. N Engl J Med 1984;310:106–114.Google Scholar

Kint, JA: Fabry’s disease: Alpha-galactosidase deficiency. Science 1970;167:1268–1269.Google Scholar

Eng, CM, Guffon, N, Wilcox, WR, et al: Safety and efficacy of recombinant human alpha-galactosidase A – replacement therapy in Fabry’s disease. N Engl J Med 2001;5:345:9–16.Google Scholar

Desnick, RJ, Brady, R, Barranger, J, et al: Fabry disease, an under-recognized multi-systemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138:338–346.Google Scholar

Kolodny, E, Fellgiebel, A, Hilz, MJ, et al: Cerebrovascular involvement in Fabry disease. Current status of knowledge. Stroke 2015;46:302–313.Google Scholar

Chabriat, H, Bousser, M-G: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 115–122.Google Scholar

Tournier-Lasserve, E, Iba-Zizen, M-T, Romero, N, Bousser, M-G: Autosomal dominant syndrome with stroke-like episodes and leukoencephalopathy. Stroke 1991;22:1297–1302.Google Scholar

Mas, JL, Dilouya, A, de Recondo, J: A familial disorder with subcortical ischemic strokes, dementia, and leukoencephalopathy. Neurology 1992;42:1015–1019.Google Scholar

Hutchinson, M, O’Riordan, J, Javed, M, et al: Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). Ann Neurol 1995;38:817–824.Google Scholar

Ragno, M, Tournier-Lasserve, E, Fiori, MG, et al: An Italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Ann Neurol 1995;38:231–236.Google Scholar

Dichgans, M, Mayer, M, Uttner, I, et al: The phenotypic spectrum of CADASIL: Clinical findings in 102 cases. Ann Neurol 1998;44:731–739.Google Scholar

Caplan, LR, Arenillas, J, Cramer, SC, et al: Stroke-related translational research (Review). Arch Neurol 2011;68:1110–1123.Google Scholar

Chabriat, H, Joutel, A, Dichgans, M, et al: CADASIL. Lancet Neurol 2009;8:643–653.Google Scholar

Chabriat, H, Levy, C, Taillia, H, et al: Patterns of MRI lesions in CADASIL. Neurology 1998;51:452–457.Google Scholar

Joutel, A, Corpechot, C, Ducros, A, et al: Notch 3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707–710.Google Scholar

Fukutake, T, Hirayama, K: Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension. Eur Neurol 1995;35:69–79.Google Scholar

Fukutake, T: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): From discovery to gene identification. J Stroke Cerebrovasc Dis 2011;20:85–93.Google Scholar

Menkes, J: Menkes disease (kinky hair disease). In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 225–230.Google Scholar

Menkes, J, Alter, M, Steigleder, G, et al: A sex-linked recessive disorder with retardation of growth, peculiar hair and focal cerebral and cerebellar degeneration. Pediatrics 1962;29:764–779.Google Scholar

Moller, JV, Juul, B, Le Maire, M: Structural organization, ion transport, and energy transduction of P-type ATP-ases. Biochem Biophys Acta 1996;1286:1–51.Google Scholar

Moller, LB, Tumer, Z, Lund, C, et al: Similar splice-site mutations of the ATP7A gene lead to different phenotypes: Classical Menkes disease or occipital horn syndrome. Am J Hum Genet 2000;66:1211–1220.Google Scholar

Iannaccone, ST, Rosenberg, RN: Menkes disease. In Berg, B (ed): Principles of Child Neurology. New York: McGraw-Hill, 1995, pp 473–475.Google Scholar

Morgello, S, Peterson, HD, Kahn, LJ, Laufer, H: Menkes kinky hair disease with “ragged red fibers.” Dev Med Child Neurol 1988;30:812–816.Google Scholar

Kaler, S, Holmes, CS, Goldstein, DS, et al: Neonatal diagnosis and treatment of Menkes disease. N Engl J Med 2008;358:605–614.Google Scholar

Nedeltchev, N, Mattle, HP: Cerebrovascular manifestations of neurofibromatosis. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 221–224.Google Scholar

Taboada, D, Alonso, A, Moreno, J: Occlusion of the cerebral arteries in Recklinghausen’s disease. Neuroradiology 1979;18:281–284.Google Scholar

Levinsohn, PM, Mikhael, MA, Rothman, SM: Cerebrovascular changes in neurofibromatosis. Dev Med Child Neurol 1978;20:789–793.Google Scholar

Rizzo, JF, Lessell, S: Cerebrovascular abnormalities in neurofibromatosis type l. Neurology 1994;44:1000–1002.Google Scholar

Boers, GH, Smals, AG, Trijbels, FJ, et al: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive disease. N Engl J Med 1985;313:709–715.Google Scholar

Welch, GN, Loscalzo, J: Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042–1050.Google Scholar

Caplan, LR, Hurst, JW: Homocysteinemia and homocystinuria. In Caplan, LR, Hurst, JW, Chimowitz, M (eds): Clinical Neurocardiology. New York: Marcel Dekker, 1999, pp 431–432.Google Scholar

Ueland, PM, Refsum, H, Stabler, SP, et al: Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764–1769.Google Scholar

Finkelstein, JD, Martin, JJ, Harris, BJ: Methionine metabolism in mammals: The methionine-sparing effect of cystine. J Biol Chem 1988;263:11750–11754.Google Scholar

Mudd, SH, Skovby, F, Levy, HL, et al: The natural history of homocystinuria due to cystathione-beta-synthase deficiency. Am J Hum Genet 1985;37:1–31.Google Scholar

Vermaak, WJ, Ubbink, JB, Barnard, HC, et al: Vitamin B₆ nutrition status and cigarette smoking. Am J Clin Nutr 1990;51:1058–1061.Google Scholar

Clarke, R, Daly, L, Robinson, K, et al: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149–1155.Google Scholar

Evers, S, Koch, H-G, Grotemeyer, K-H, et al: Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. Arch Neurol 1997;54:1276–1282.Google Scholar

Selhub, J, Jacques, PF, Bostom, AG, et al: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286–291.Google Scholar

Harker, LA, Slichter, SJ, Scott, CR: Homocysteinemia: Vascular injury and arterial thrombosis. N Engl J Med 1974;291:537–543.Google Scholar

Harker, LA, Ross, R, Slichter, SJ, Scott, CR: Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976;58:731–741.Google Scholar

Tsai, J-C, Perrella, MA, Yoshizumi, M, et al: Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci U S A 1994;91:6369–6373.Google Scholar

Roach, ES, Anselm, I, Rosman, NP, Caplan, LR: Progeria. In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 145–148.Google Scholar

Merideth, MA, Gordon, LB, Clauss, S, et al: Phenotype and course of Hutchinson–Gilford progeria syndrome. N Engl J Med 2008;358:592–604.Google Scholar

Delgado Luengo, W, Rojas Martinez, A, Ortiz Lopez, R, et al: Del(1)(q23) in a patient with Hutchinson–Gilford progeria. Am J Med Genet 2002;113:298–301.Google Scholar

McClintock, D, Gordon, LB, Djabali, K: Hutchinson–Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-lamin A G608 G antibody. Proc Natl Acad Sci U S A 2006;103:2154–2159.Google Scholar

Zuber, M: Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu disease). In Caplan, LR (ed): Uncommon Causes of Stroke, 2nd ed. Cambridge: Cambridge University Press, 2008, pp 109–114.Google Scholar

Osler, W: On a family form of recurring epistaxis, associated with multiple telengiectases of the skin and mucous membranes. John Hopkins Hosp Bull 1901;12:333–337.Google Scholar

Peery, WH: Clinical spectrum of hereditary haemorrhagic telengiectasia (Osler–Weber–Rendu disease). Am J Med 1987;82:989–997.Google Scholar

Guttmacher, AE, Marchuk, DA, White, RI: Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918–924.Google Scholar

Gould, DB, Phalan, FC, Breedveld, GJ, et al: Mutations in COL4A1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005;308:1167–1171.Google Scholar

Gould, DB, Phalan, FC, van Mil, SE, et al: Role of COL4A1 in small vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489–1496.Google Scholar

Vahedi, K, Boukobza, M, Massin, P, et al: Clinical and brain MRI follow-up study of a family with COL4A1 mutation. Neurology 2007;69:1564–1568.Google Scholar

Meschia, JF, Rosand, J: Fragile vessels. Handle with care. Neurology 2007;69:1560–1561.Google Scholar

Labrune, P, Lacroix, C, Goutieres, F, et al: Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts: A new progressive disorder due to diffuse cerebral microangiopathy. Neurology 1996;46:1297–1301.Google Scholar

Corboy, JR, Gault, J, Kleinschmidt-Demasters, BK: An adult case of leukoencephalopathy with intracranial calcifications and cysts. Neurology 2006;67:1890–1892.Google Scholar

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Non-atherosclerotic vasculopathies
- By Louis R Caplan, José Biller
Edited by Louis R. Caplan
Book: Caplan's Stroke
Online publication: 05 August 2016
Chapter DOI: https://doi.org/10.1017/CBO9781316095805.013

Your Kindle email address

@free.kindle.com @kindle.com (service fees apply)

Available formats PDF

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services